
<html lang="en"     class="pb-page"  data-request-id="86a2c70c-a3a7-4707-bd16-aad6528b0411"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.6b01083;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases" /></meta><meta name="dc.Creator" content="Apirat  Chaikuad" /></meta><meta name="dc.Creator" content="Julien  Diharce" /></meta><meta name="dc.Creator" content="Martin  Schröder" /></meta><meta name="dc.Creator" content="Alicia  Foucourt" /></meta><meta name="dc.Creator" content="Bertrand  Leblond" /></meta><meta name="dc.Creator" content="Anne-Sophie  Casagrande" /></meta><meta name="dc.Creator" content="Laurent  Désiré" /></meta><meta name="dc.Creator" content="Pascal  Bonnet" /></meta><meta name="dc.Creator" content="Stefan  Knapp" /></meta><meta name="dc.Creator" content="Thierry  Besson" /></meta><meta name="dc.Description" content="Methyl 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK’s family kinases. The crystal structures of the complex revealed a noncanonical..." /></meta><meta name="Description" content="Methyl 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK’s family kinases. The crystal structures of the complex revealed a noncanonical..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 2, 2016" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01083" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01083" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01083" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01083" /></link>
        
    
    

<title>An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01083" /></meta><meta property="og:title" content="An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0008.jpeg" /></meta><meta property="og:description" content="Methyl 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK’s family kinases. The crystal structures of the complex revealed a noncanonical binding mode of compounds 1 and 2 in DYRK2, explaining the remarkable selectivity and potency of these inhibitors. The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01083"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01083">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01083&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01083&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01083&amp;href=/doi/10.1021/acs.jmedchem.6b01083" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10315-10321</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01459" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.6b01190" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-<i>f</i>] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Apirat++Chaikuad">Apirat Chaikuad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julien++Diharce">Julien Diharce</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Schr%C3%B6der">Martin Schröder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alicia++Foucourt">Alicia Foucourt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bertrand++Leblond">Bertrand Leblond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Sophie++Casagrande">Anne-Sophie Casagrande</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++D%C3%A9sir%C3%A9">Laurent Désiré</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Bonnet">Pascal Bonnet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Knapp">Stefan Knapp</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Besson">Thierry Besson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Target Discovery Institute (TDI), and Structural Genomics Consortium (SGC), University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institut de Chimie Organique et Analytique, UMR CNRS-Université d’Orléans 7311, Université d’Orléans, BP 6759, Orléans 45067 Cedex 2, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Pharmaceutical Chemistry and Buchman Institute for Life Sciences, Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt am Main, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Normandie Univ, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, 76000 Rouen, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Diaxonhit, 63-65 Boulevard Masséna, 75013 Paris, France</span></div><div class="corresp-info"><strong>*</strong>For T.B.: phone, +33 (0)235 622 904; fax, +33 (0)235 148 423; E-mail, <a href="/cdn-cgi/l/email-protection#c7b3afaea2b5b5bee9a5a2b4b4a8a987b2a9aeb1eab5a8b2a2a9e9a1b5"><span class="__cf_email__" data-cfemail="fb8f93929e898982d5999e88889495bb8e95928dd689948e9e95d59d89">[email protected]</span></a>; address, COBRA UMR CNRS 6014, Université de Rouen, Batiment IRCOF, Rue Tesniere, Mont Saint Aignan cedex F076821, France.</div><div class="corresp-info"><strong>*</strong>For S.K.: phone, +49 69798-29871; E-mail, <a href="/cdn-cgi/l/email-protection#680306091818281800091a050b000d05461d0601450e1a0906030e1d1a1c460c0d"><span class="__cf_email__" data-cfemail="dbb0b5baabab9babb3baa9b6b8b3beb6f5aeb5b2f6bda9bab5b0bdaea9aff5bfbe">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01083&amp;href=/doi/10.1021%2Facs.jmedchem.6b01083" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10315–10321</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 21, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 July 2016</li><li><span class="item_label"><b>Published</b> online</span>2 November 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01083" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01083</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10315%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DApirat%2BChaikuad%252C%2BJulien%2BDiharce%252C%2BMartin%2BSchr%25C3%25B6der%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D22%26contentID%3Dacs.jmedchem.6b01083%26title%3DAn%2BUnusual%2BBinding%2BModel%2Bof%2Bthe%2BMethyl%2B9-Anilinothiazolo%255B5%252C4-f%255D%2Bquinazoline-2-carbimidates%2B%2528EHT%2B1610%2Band%2BEHT%2B5372%2529%2BConfers%2BHigh%2BSelectivity%2Bfor%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinases%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10321%26publicationDate%3DNovember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01083"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1962</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01083" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Apirat&quot;,&quot;last_name&quot;:&quot;Chaikuad&quot;},{&quot;first_name&quot;:&quot;Julien&quot;,&quot;last_name&quot;:&quot;Diharce&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Schröder&quot;},{&quot;first_name&quot;:&quot;Alicia&quot;,&quot;last_name&quot;:&quot;Foucourt&quot;},{&quot;first_name&quot;:&quot;Bertrand&quot;,&quot;last_name&quot;:&quot;Leblond&quot;},{&quot;first_name&quot;:&quot;Anne-Sophie&quot;,&quot;last_name&quot;:&quot;Casagrande&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Désiré&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Bonnet&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Knapp&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Besson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10315-10321&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01083&quot;},&quot;abstract&quot;:&quot;Methyl 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK’s family kinases. The crystal structures of the complex revealed a noncanonical binding mode of compounds 1 and 2 in DYRK2, explaining the remarkable selectivity and potency of these inhibitors. The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01083&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01083" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01083&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01083" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01083&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01083" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01083&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01083&amp;href=/doi/10.1021/acs.jmedchem.6b01083" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01083" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01083" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26pmid%3D27766861%26genre%3Darticle%26aulast%3DChaikuad%26date%3D2016%26atitle%3DAn%2BUnusual%2BBinding%2BModel%2Bof%2Bthe%2BMethyl%2B9-Anilinothiazolo%255B5%252C4-f%255D%2Bquinazoline-2-carbimidates%2B%2528EHT%2B1610%2Band%2BEHT%2B5372%2529%2BConfers%2BHigh%2BSelectivity%2Bfor%2BDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D22%26spage%3D10315%26epage%3D10321%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/jmcmar.2016.59.issue-22/20161123/jmcmar.2016.59.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Methyl 9-anilinothiazolo[5,4-<i>f</i>]quinazoline-2-carbimidates <b>1</b> (EHT 5372) and <b>2</b> (EHT 1610) are strong inhibitors of DYRK’s family kinases. The crystal structures of the complex revealed a noncanonical binding mode of compounds <b>1</b> and <b>2</b> in DYRK2, explaining the remarkable selectivity and potency of these inhibitors. The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases catalyze protein phosphorylation, a key cellular regulatory mechanism, which is frequently dysregulated in human diseases. Kinases have therefore been linked to the development of a variety of diseases including cancer, neurodegenerative disorders, and cardiovascular diseases.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Consequently, protein kinases represent pertinent targets for academic and industrial chemists developing inhibitors as potential new therapeutic agents.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Most kinases target serine (Ser) and threonine (Thr) residues as substrates, others specifically phosphorylate tyrosines (Tyr), and a number (dual-specificity kinases or DYRKs) may phosphorylate under certain circumstances all three residues. DYRKs belong to the CMGC group of Ser/Thr kinases, which also includes cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAPKs), glycogen synthase kinases (GSKs), and CDC2-like kinases (CLKs). During translation and folding, DYRKs autophosphorylate their own activation loop on a tyrosine residue. After this initial tyrosine phosphorylation, DYRKs convert to Ser/Thr kinases.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> In human, the DYRK family includes five members: DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4 and the more distant member Pre-MRNA processing factor 4 (PRP4). All share considerable sequence identity in their kinase domain.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> DYRK1A is certainly the most studied family member and has attracted considerable interest due to its role in Down syndrome pathology and its suspected role in neurodegenerative diseases, cancer,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and diabetes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">DYRK1A has been shown to phosphorylate more than 30 proteins to regulate diverse biological functions, including synaptic transmission, neurodegeneration, transcription, mRNA splicing, cell proliferation, and survival.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> DYRK1B (also called Mirk for minibrain-related kinase) is potentially an attractive cancer target that is highly expressed in quiescent cancer cells while it is expressed at very low levels in normal tissue. It has been hypothesized that pharmacological DYRK1B inhibition would enable cancer cells to escape from quiescence, triggering apoptosis, and resensitize cancer cells to conventional chemotherapeutic agents.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">An important role of DYRK1A in a number of diseases and the unknown functions of other family members have prompted an interest in the development of potent and selective inhibitors for DYRK kinases. Since the discovery of a plant alkaloid harmine as potent DYRK1A inhibitor with IC<sub>50</sub>s of 30–80 nM,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> a number of efforts have led to diverse potent inhibitors, including INDY,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> natural product leucettine L41,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and pyrido[2,3-<i>d</i>]pyrimidines-based inhibitors<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with reported IC<sub>50</sub>s in the range of 9–240 nM. However, these early inhibitors often significantly cross-react with other kinases such as GSK3β and CLKs and in the case of harmine with other enzymes. Recently, the discovery of a new chemical class has led to another potent and selective DYRK1A inhibitor, 10-iodo-11<i>H</i>-indolo[3,2-<i>c</i>]quinoline-6-carboxylic acid (known also as inhibitor <b>5j</b>), with a reported IC<sub>50</sub> of 6 nM demonstrating at least 80-fold more potency over other related kinases.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nonetheless, an obstacle for its use is its poor cellular activity.</div></div><div id="sec98" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous efforts have demonstrated the usefulness of thiazolo[5,4-<i>f</i>]quinazolines for the development of GSK3β and CDK1 inhibitors.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> We further considered a possible use of this chemical scaffold toward the development of DYRKs inhibitor because these kinases share some similarity and belong to the same CMGC family. DYRK1A and 1B were our targets of interest due to their strong links to diseases. However, their high sequence identity of ∼85% suggested that isoform selective inhibitors could represent a big challenge; hence, we limited our aim in this current study to dual inhibitors, allowing us to focus on the synthetic chemistry. To functionalize and decorate the scaffold, we applied our previously described microwave-assisted synthetic routes and the use of Appel salt (4,5-dichloro-1,2,3-dithiazolium chloride) for the conception of a 6-amino-2-cyanobenzo[<i>d</i>]thiazole-7-carbonitrile derivative as a versatile molecular platform from 5-nitroanthranilonitrile. The introduction of various aliphatic, aromatic, or amino substituents at position 8 was best achieved by a one-pot DMFDMA-mediated cyclization.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Transformation of carbonitrile group into various chemical functions (e.g., imidate, ester, amide, and amidine) allowed the efficient preparation of a library of 110 novel methyl 9-anilinothiazolo[5,4-<i>f</i>]quinazoline-2-carbimidate derivatives.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a></div><div class="NLM_p">We previously tested this library for their effectiveness against DYRK1A and DYRK1B, and most of them showed similar or better inhibitory potency compared to harmine.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Interestingly, among them the five most active molecules prepared in this study were <b>1</b> (EHT 5372), <b>2</b> (EHT 1610), <b>3</b> (EHT 9851), <b>4</b> (EHT 6840), and <b>5</b> (EHT 3356), which harbored a phenyl group at <sup>9</sup><i>N</i> which was disubstituted in <i>ortho</i> and <i>para</i> by halogen atoms (Cl and F) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). In the case of <b>2</b> (EHT 1610), a fluor atom in <i>ortho</i> was accompanied by a methoxy group in <i>para</i>, and in the case of <b>5</b> (EHT 3356) only a methyl group in the <i>para</i> position.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> These compounds exhibited strong potency with IC<sub>50</sub> values in the subnanomolar to single-digit nanomolar range for DYRK1A (0.22–0.99 nM) and DYRK1B (0.28–2.83 nM).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of methyl 9-anilinothiazolo[5,4-<i>f</i>]quinazoline-2-carbimidates <b>1</b>–<b>5</b> and DYRK1A and DYRK1B IC<sub>50</sub> (nM) values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the five top hits, the most potent inhibitors in this series were methyl 9-(2,4-dichlorophenylamino)thiazolo[5,4-<i>f</i>]quinazoline-2-carbimidate (<b>1</b>) and methyl 9-(2-chloro,4-methoxyphenylamino)thiazolo[5,4-<i>f</i>]quinazoline-2-carbimidate (<b>2</b>) that exhibited IC<sub>50</sub>s of 0.22/0.28 nM and 0.36/0.59 nM for DYRK1A/1B, respectively.</div><div class="NLM_p">We next examined their potency and selectivity against a small panel of closely related kinases, including for example DYRK1A, DYRK2, PRP4, CLK1/3, GSK3α/β, PIM1, and SRPK1, using differential scanning fluorimetry (DSF) (Tm shift assay). As expected, both compounds showed good binding to their target DYRK1A with Tm shift of ∼9 °C and demonstrated a good selectivity (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). However, we also observed interaction of three off-targets, DYRK2, CLK1, and GSK3β, albeit with significantly smaller Tm shifts in the range of 5–6 °C. The observed good selectivity to closely related kinases was in agreement with our comprehensive kinome-wide screening study, which showed remarkably high selectivity over 339 kinases.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Interestingly, both independent assays detected a similar set of off-targets with significantly weaker inhibition (IC<sub>50</sub>s in the range of 3.2 to >1570 nM), which was supported by the lower Tm shift observed here (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selectivity analysis of <b>1</b> and <b>2</b>: Tm shifts (A) and IC<sub>50</sub> values (B) for selected kinases screened against <b>1</b> and <b>2</b>. n/a = no inhibition detected,  <i><sup>a</sup></i>Values from ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, we also observed remarkable selectivity within DYRKs family. DYRK2 was the strongest off-target with IC<sub>50</sub>s for <b>1</b> and <b>2</b> of 10.8 and 3.16 nM, respectively, which was despite the high homology still ∼38- and 5-fold weaker when compared to DYRK1A/1B. Of particular interest were differences in selectivity and potency of <b>1</b> and <b>2</b>. One of the main differences between these compounds was a substitution of the Cl and methoxy groups at the R<sup>2</sup> position, respectively. Switching halide to methoxy groups led to lower inhibitory effect for DYRK1A/1B by ∼2-fold. On the contrary, this substitution instead significantly increased the potency toward other off-targets, essentially DYRK2.</div><div class="NLM_p">To provide the structural insights into the binding modes of these two inhibitors, we attempted to cocrystallize <b>1</b> and <b>2</b> with DYRK1A but did not succeed in obtaining crystals that diffracted to high resolution. We therefore performed cocrystallization of both compounds with DYRK2, and this led to successful structure determination of the DYRK2–<b>1</b> and −<b>2</b> complexes to 2.15 and 2.58 Å resolution, respectively (Supporting Information (SI), <a href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_p">We observed interpretable electron density for both ligands (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), allowing confident modeling of the inhibitors within the pocket. The binding modes of both inhibitors were remarkably similar (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of DYRK2 in complexes with <b>1</b> and <b>2</b>. (A) |<i>F</i><sub>O</sub>| – |<i>F</i><sub>C</sub>| omitted map contoured at 3.0σ for the bound inhibitors. (B) Detailed interactions of the binding modes of the inhibitors with DRYK2. Magenta, dashed lines indicates potential hydrogen bonds, and water molecules are shown as cyan spheres. (C) Superimposition of DYRK2–<b>1</b>, DYRK1A–harmine (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>), DYRK1A–inhibitor <b>5j</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YLJ">4YLJ</a>), and DYRK1A–leucettine L41 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AZE">4AZE</a>) reveals that <b>1</b> occupies large space inside the DYRK ATP pocket. Note that numbering is according to DYRK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In brief, the heterocyclic thiazolo[5,4-<i>f</i>]quinazoline was located deep within the ATP binding site and sandwiched by Val163 and Ile294. This orientation placed the thiazolo adjacent to the gatekeeper Phe228 and positioned the N1 nitrogen group of the quinazoline ring for a hydrogen bond interaction within the salt bridge Lys178. The methyl-carbimidate decoration pointed toward the hinge with its nitrogen group at 3.1–3.6 Å away from the backbone of the hinge residues Glu229 and Leu231, thus not interacting strongly with the hinge region.</div><div class="NLM_p">In contrast, optimal hydrogen interactions were observed in the backpocket where the quinazoline nitrogen was engaged in a hydrogen bond network with a conserved lysine/glutamate ion pair. In addition, the aromatic gatekeeper (Phe228) formed a π–π-stacking interaction with the central aromatic ring system of the inhibitor. The 2-chloro or 2-fluoro R<sup>1</sup> decoration of this group was ∼3.3–3.7 Å away from the P-loop Phe160 that was observed to adopt a distorted “folded-in” conformation, a structural alteration which has been reported to often confer selectivity. Conversely, the chloro or methoxy decoration at R<sup>2</sup> position pointed outward to the solvent exterior with no interaction observed.</div><div class="NLM_p">The observed binding mode provided no direct evidence on why this R<sup>2</sup> substitution altered potency and selectivity between these two inhibitors. However, the observed ∼21–30° tilt of the aniline group suggested that the change of charges, size, and van der Waal radii in this position most likely affects interaction within the cavity created between the P-loop and the C-lobe αD and β7, which often possess significantly different features among different kinases. In addition, the difference in size and electrostatic property of the halides at R<sup>1</sup> position could also contribute their effects toward the affinities when bound in proximity to the aromatic Phe160.</div><div class="NLM_p">The observed binding mode of the core thiazolo[5,4-<i>f</i>]quinazoline scaffold in DYRK2 was rather unexpected when compared to the predicted binding mode of a similar derivative in GSK3β, where the heterocyclic core was proposed to adopt a canonical hinge binding, with the quinazoline interacting with the hinge backbone pointing the carbimidate toward the catalytic salt bridge for potential hydrogen bond.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> The flip of the ring in DYRK2 resulted in a loss of strong canonical hinge interaction yet maintain a hydrogen bond to the salt bridge but through the quinazoline moiety. Such different accommodation mechanisms of the core ATP-mimetic scaffold between these two kinases could form a basis of selectivity between DYRKs and other closely related kinases. However, it should be noted that the binding mode of this core scaffold in GSK3β was based on a docking study, unlike that in DYRK2, which was observed in the crystal structures. We then compared the binding modes of these compounds with other known DYRK inhibitors, including harmine, leucettine L41, and inhibitor <b>5j</b>. Structural comparison revealed that all inhibitors did superimpose well with similarity regarding the planarity and orientation of their core scaffolds (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). In essence, the binding geometry of our compounds highly resembled that of leucettine L41, of which the phenyl group adopted also a nearly perpendicular vertical conformation in a similar manner to the aniline moiety of our inhibitors. Interestingly, unlike <b>1</b> and <b>2</b>, other known inhibitors maintain a hinge interaction either via hydrogen or halogen bond.</div><div class="NLM_p">To provide the binding modes of <b>1</b> and <b>2</b> in the target DYRK1A/1B, we performed docking studies with DYRK1A and that coupled with structural modeling of DYRK1B (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf" class="ext-link">SI</a>). The calculated models revealed that both inhibitors assumed identical binding modes as those observed in the crystal structures of DYRK2 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Modeling of <b>1</b> and <b>2</b> with DYRK1A/1B. Potential binding modes of <b>1</b> (left) and <b>2</b> (right) in DYRK1B calculated from structural modeling and docking studies (yellow, hinge region; red, catalytic loop; blue, DFG motif; purple, α-C helix; orange, catalytic lysine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The core thiazolo[5,4-<i>f</i>]quinazoline would adopt the similar planar geometry, with the quinazoline engaging a hydrogen bond with the salt bridge lysine. Interestingly, we predicted that the carbimidate nitrogen forms improved canonical hinge interaction with the hinge backbone of Ile241 or Ile193 in DRYK1A and 1B. This observation could be the structural basis of the significant increase in affinities of both inhibitors toward DYRK1A/1B. On the basis of our docking data, the aniline moiety assumed several conformations due to its position in proximity to solvent-exposed area, again offering no direct evidence why the R<sup>2</sup> chloro- and methoxy-substitution altered affinities by ∼2–3-fold.</div><div class="NLM_p">Overall structural comparison suggested that the canonical hinge may be less essential for high affinity binding in DYRKs. The unusual binding mechanisms of <b>1</b> and <b>2</b> occupied a large portion of the ATP binding pocket, essentially covering nearly all cavities targeted by the other three inhibitors compared here (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). Calculations of the changes of solvent-accessible surface area (SASA) due to ligand binding revealed that <b>1</b> and <b>2</b> are 92% and 88% buried in DYRK2 and by docking 86% and 83% binding to DYRK1A, respectively.</div><div class="NLM_p">In addition, studies of the thermodynamics of the unusual binding mode by isothermal titration calorimetry (ITC) revealed also that inhibitor binding was driven by a large negative binding enthalpy. The <i>K</i><sub>d</sub> was determined to be 7.4 ± 4 nM. However, due to the high affinity of <b>2</b>, the affinity measurements were associated with a large error. The indirectly determined entropy term (<i>T</i>Δ<i>S</i>) was unfavorable. (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ITC binding data of <b>2</b> with DYRK1A. Shown are the isotherms of raw titration heat (left), and the normalized binding heat with the single-site fitting (red line) (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next performed the sequence alignment of the kinase domains of DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4 to analyze the basis of selectivity of the inhibitors within DYRK family. The results revealed a well-conserved active site of the DYRK1 and DYRK2 subfamilies (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Further analyses revealed that DYRK1A and DYRK1B had a higher percentage of identity and similarity of 85.0% and 93.1%, respectively, and this was the case also for DYRK2 and DYRK3 (identity = 79.0%, similarity = 89.5%). DYRK4 was an outlier in the family, sharing <60% and <80% sequence identity and similarity, respectively, to other members (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). On the basis of these statistics, it was therefore possible to classify the kinases into three clusters; (i) DYRK1A/1B, (ii) DYRK2/3, and (iii) DYRK4. This result from sequence alignment was consistent with the trend in affinities of both inhibitors with no or weak inhibition for DYRK4, moderate binding for DYRK2/3, and high potency for DYRK1A/1B. Because no crystal structure is currently available for this kinase, we postulated that overall features and environment of the ATP pocket of DYRK4 is significantly different from that of the other DYRKs. Despite low sequence identity and similarity, the possible binding with moderate potency of the inhibitors in DYRK2 was supported by the similarity in environment of the ATP pocket to that of DYRK1A. However, subtle differences at the backpocket between DYRK2/3 and DYRK1A/1B clusters, including the residue before DFG motif (DYRK2 Ile294/DYRK1A Val306) and the residue at the beginning of β4 (DYRK2 Ile212/DYRK1A Val222), might form the basis of a significant change in affinities between these two subclasses.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Sequence alignment of DYRK family. (A) Sequence alignment of the region within the ATP binding pockets of DYRK family. Sequence similarity (%) to other DYRK kinases is represented by a blue bar. (B) Percentages of identity (bottom left quadrant) and similarity (top right quadrant) of kinase domain sequences from members of DYRK1 and DYRK2 subfamilies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Because the inhibitors interacted with these residues in the backpocket, the bulkier sizes of isoleucine in DYRK2 could lead to more steric hindrance compared to the smaller valine in DYRK1A. Indeed, in silico mutation demonstrated that the substitution of the corresponding DYRK1A/B valine into isoleucine caused a subtle shift of the binding positions of the inhibitors in comparison to that of the wild type. This observation support differences in the observed inhibitor potencies between the DYRK1A/1B and DYRK2/3. Nonetheless, further experiments may be required to fully understand the impact of these differences on the binding mode of <b>1</b> and <b>2</b> within these two DYRKs subfamilies.</div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">To our knowledge, the two compounds presented here are the most potent and selective DYRK1A/1B inhibitors reported to date. We have previously demonstrated that <b>1</b> was active in cells and inhibited DYRK1A-induced Tau phosphorylation at multiple sites in biochemical assay, cell lines, and primary cortical neurons without affecting cell viability. Inhibitor <b>1</b> compared favorably to harmine, leucettine L41, and to the reactive and promiscuous compound epigallo-catechin-gallate EGCG<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, it normalized Aβ-induced Tau phosphorylation in neuronal cells and also normalized DYRK1A-induced Aβ production in APP overexpressing cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, in vitro characterization in various cancer cellular models showed that the inhibitor targeted G0/G1 transition and reduced stemness and EMT properties of cancer cells organized in spheroids.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Furthermore, it demonstrated promising activities in patient-derived ovarian cancer ascites spheroids and in vivo activities in a Panc1 xenograft model without detectable toxicity in mice.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Similar to <b>1</b>, <b>2</b> has been previously observed to dose-dependently inhibit DYRK1A in both B- and T-lineage acute lymphoblastic leukemia (ALL).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In addition, the inhibitors also induced apoptosis of primary ALL cells that were resistant to cytarabine, suggesting that DYRK1A inhibitors may be used in combination with standard ALL therapies for refractory or relapsed cases.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These results suggested that both compounds not only exhibited high potency in vitro but demonstrated also good activities in cell-based systems and in vivo models. These data therefore suggest a potential use of this class of inhibitors for targeting cancer cells with high DYRK1A/1B kinase activities.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33">(27-33)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Complete and detailed synthesis of inhibitors <b>1</b> (EHT 5372) and <b>2</b> (EHT 1610) used in this study have been described in refs <a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">24, 25</a>, and <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>. The target compounds <b>1</b> and <b>2</b> were obtained in nine steps from 5-nitroanthranilonitrile in overall yields of 6% and 14%, respectively.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> General Procedures</h3><div class="NLM_p">Materials were obtained commercially and used without further purification. All reactions were carried out under inert atmosphere of argon or nitrogen and monitored by thin-layer chromatography with silica gel 60 F254 precoated aluminum plates (0.25 mm). Visualization was performed with a UV light at 254 and 312 nm. Purifications were carried out by flash column chromatography system equipped with a dual UV–vis spectrophotometer (200–600 nm), a frion collector (176 tubes), a dual pistopump (1–200 mL/min, Pmax = 15 bar), allowing quaternary gradients and an additional inlet for air purge. Samples can be injected in liquid or solid mode. Melting points of solid compounds were measured on a Stuart melting point SMP3 with a precision of ±1.5 °C. IR spectra were recorded on a PerkinElmer Spectrum 100 series FT-IR spectrometer. Liquids and solids were applied on the section attenuated total reflectance (ATR) accessories. Absorption bands are given in cm<sup>–1</sup>. <sup>1</sup>H, <sup>19</sup>F NMR spectra were recorded at 295 K on a Bruker AVANCE 300 MHz, at 300 relative to CDCl<sub>3</sub> (residual solvent signals). Mass spectra analysis was performed by the Mass Spectrometry Laboratory of the University of Rouen. Mass spectra (ESI) were recorded with a Waters LCP 1er XR spectrometer. Microwave experiments were conducted at atmospheric pressure (RotoSYNTH, Milestone Srl, Italy) or in pressurized reactors (0–30 bar) (Monomode 300, Anton Paar, France) in commercial microwave reactors especially designed for synthetic chemistry. The purity of all tested compounds was determined by chromatographic analysis performed at 25 °C on Ultimate 3000 (Thermo Scientific, Les Ulis, France) with a binary pump and photodiode array detector (DAD) managed at 289 nm. Column was a Pursuit XRS (250 mm × 4.6 mm; 5 μm particle size) provided by Varian (Les Ulis, France). The mobile phase was H<sub>2</sub>O/AcCN (40:60; v/v). Flow rate was 1 mL/min, and 20 μL were injected. The percentage of purity of all products was more than 96%.</div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Methyl 9-(2,4-Dichlorophenylamino)thiazolo[5,4-<i>f</i>]quinazoline-2-carbimidate (<b>1</b>)</h4><div class="NLM_p last">Flash chromatography eluent (EtOAc). Yellow solid. Overall yield: 6%, mp >260 °C. IR (cm<sup>–1</sup>) ν<sub>max</sub> 2953, 1727, 1641, 1586, 1507, 1488, 1464, 1394, 1354, 1284, 1158, 1099, 1073, 1054, 941, 860, 816. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.34 (s, 1H, NH), 8.45 (d, 1H, <i>J</i> = 9.0 Hz), 8.10 (s, 1H), 7.72 (d, 1H, <i>J</i> = 9.0 Hz), 7.61 (s, 1H), 7.37 (d, 1H, <i>J</i> = 8.1 Hz), 7.18 (d, 1H, <i>J</i> = 8.1 Hz), 3.94 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>12</sub>N<sub>5</sub>OSCl<sub>2</sub> [M + H]<sup>+</sup>, 404.0140; found, 404.0146.</div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Methyl 9-(2-Fluoro-4-methoxyphenylamino)thiazolo[5,4-<i>f</i>]quina-zoline-2-carbimidate (<b>2</b>)</h4><div class="NLM_p last">Flash chromatography eluent (EtOAc). Yellow solid. Overall yield: 14%, mp = 224–226 °C (2-propanol). IR (cm<sup>–1</sup>) ν<sub>max</sub> 3150, 2950, 1645, 1601, 1570, 1488, 1435, 1355, 1322, 1285, 1269, 1203, 1155, 1096, 1069, 1032, 939, 819. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −120.44. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H, NH), 8.28 (d, 1H, <i>J</i> = 9.0 Hz), 8.06 (s, 1H), 7.62 (d, 1H, <i>J</i> = 9.0 Hz), 7.39 (m, 1H), 6.81 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 6.71 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 3.94 (s, 3H), 3.75 (s, 3H). HRMS calcd for C<sub>18</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub>SF [M + H]<sup>+</sup>, 384.0927; found, 384.0930.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01083">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01083" class="ext-link">10.1021/acs.jmedchem.6b01083</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed synthesis of <b>1</b> (EHT 5372) and <b>2</b> (EHT 1610), <sup>1</sup>H NMR spectra, and HPLC chromatograms for <b>1</b> and <b>2</b>, details of docking experiments, protein expression and purification, thermal stability assays, docking experiments of <b>1</b> and <b>2</b> in DYRK1A and DYRK1B, isothermal titration calorimetry (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf">jm6b01083_si_001.pdf (624.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_002.csv">jm6b01083_si_002.csv (0.43 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The structure coordinates have been deposited in the Protein Data Bank: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC">5LXC</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD">5LXD</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01083" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Knapp</span> - <span class="hlFld-Affiliation affiliation">Target
Discovery Institute (TDI), and Structural Genomics Consortium (SGC), University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry and Buchman Institute for Life Sciences, Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt am Main, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#117a7f70616151617970637c7279747c3f647f783c7763707f7a776463653f7574"><span class="__cf_email__" data-cfemail="e2898c839292a2928a83908f818a878fcc978c8bcf8490838c8984979096cc8687">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Besson</span> - <span class="hlFld-Affiliation affiliation">Normandie
Univ, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, 76000 Rouen, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a6e72737f68686334787f696975745a6f74736c3768756f7f74347c68"><span class="__cf_email__" data-cfemail="dda9b5b4b8afafa4f3bfb8aeaeb2b39da8b3b4abf0afb2a8b8b3f3bbaf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Apirat Chaikuad</span> - <span class="hlFld-Affiliation affiliation">Target
Discovery Institute (TDI), and Structural Genomics Consortium (SGC), University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julien Diharce</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, UMR CNRS-Université d’Orléans
7311, Université d’Orléans, BP 6759, Orléans 45067 Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Schröder</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry and Buchman Institute for Life Sciences, Goethe-University, Max-von-Laue-Strasse 9, 60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alicia Foucourt</span> - <span class="hlFld-Affiliation affiliation">Normandie
Univ, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, 76000 Rouen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bertrand Leblond</span> - <span class="hlFld-Affiliation affiliation">Diaxonhit, 63-65 Boulevard Masséna, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Sophie Casagrande</span> - <span class="hlFld-Affiliation affiliation">Diaxonhit, 63-65 Boulevard Masséna, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Désiré</span> - <span class="hlFld-Affiliation affiliation">Diaxonhit, 63-65 Boulevard Masséna, 75013 Paris, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Bonnet</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, UMR CNRS-Université d’Orléans
7311, Université d’Orléans, BP 6759, Orléans 45067 Cedex 2, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.B. and B.L. conceived and designed the project. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d67e1043-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from the Ministère de l’Enseignement Supérieur & de la Recherche (MESR) is gratefully acknowledged for the doctoral fellowships to A.F. AC is supported by the EU network fellowship PRIMES. SK is grateful for support by the SGC, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust as well as the Innovative Medicines Initiative (EU/EFPIA) grant K4DD. We thank the staffs at Diamond Light Source, Beamline I04-1, for assistance during data collection. A.F., P.B., and T.B. are supported by LABEX SynOrg (ANR-11-LABX-0029).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i12" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i12"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i13" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i13"> Abbreviations Used</h2><tr><td class="NLM_term">DMFDMA</td><td class="NLM_def"><p class="first last">dimethylformamidedimethylacetamide</p></td></tr><tr><td class="NLM_term">DYRKs</td><td class="NLM_def"><p class="first last">dual specificity tyrosine phosphorylation-regulated kinases</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial–mesenchymal transition</p></td></tr><tr><td class="NLM_term">CLK</td><td class="NLM_def"><p class="first last">cdc2 like kinases</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaudeix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Tau protein kinases: Involvement in Alzheimer’s disease</span> <span class="citation_source-journal">Ageing Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1016/j.arr.2012.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.arr.2012.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=22742992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=289-309&author=L.+Martinauthor=X.+Latypovaauthor=C.+M.+Wilsonauthor=A.+Magnaudeixauthor=M.-L.+Perrinauthor=C.+Yardinauthor=F.+Terro&title=Tau+protein+kinases%3A+Involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arr.2012.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein kinases: Involvement in Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Wilson, Cornelia M.; Magnaudeix, Amandine; Perrin, Marie-Laure; Yardin, Catherine; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289-309</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tau phosphorylation is regulated by a balance between tau kinase and phosphatase activities.  Disruption of this equil. was suggested to be at the origin of abnormal tau phosphorylation and thereby might contribute to tau aggregation.  Thus, understanding the regulation modes of tau phosphorylation is of high interest in detg. the possible causes at the origin of the formation of tau aggregates in order to elaborate protection strategies to cope with these lesions in Alzheimer's disease.  Among the possible and specific interventions that reverse tau phosphorylation is the inhibition of certain tau kinases.  Here, we extensively reviewed tau protein kinases, their physiol. roles and regulation, their involvement in tau phosphorylation and their relevance to AD.  We also reviewed the most common inhibitory compds. acting on each tau kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU914c2pCuALVg90H21EOLACvtfcHk0ljne9czmUVhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D&md5=ce41a1cf982105ec7b3cc0ee6fcdf20b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2012.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2012.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DMagnaudeix%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.-L.%26aulast%3DYardin%26aufirst%3DC.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DTau%2520protein%2520kinases%253A%2520Involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2013%26volume%3D12%26spage%3D289%26epage%3D309%26doi%3D10.1016%2Fj.arr.2012.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-β formation by casein kinase I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4164</span><span class="refDoi"> DOI: 10.1073/pnas.0611236104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1073%2Fpnas.0611236104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-4164&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-%CE%B2+formation+by+casein+kinase+I&doi=10.1073%2Fpnas.0611236104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611236104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611236104%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-%25CE%25B2%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D4164%26doi%3D10.1073%2Fpnas.0611236104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Weinmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metternich, R.</span><span> </span><span class="NLM_article-title">Drug discovery process for kinase Inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1002/cbic.200500034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1002%2Fcbic.200500034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=15742380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=455-459&author=H.+Weinmannauthor=R.+Metternich&title=Drug+discovery+process+for+kinase+Inhibitors&doi=10.1002%2Fcbic.200500034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery process for kinase inhibitors</span></div><div class="casAuthors">Weinmann Hilmar; Metternich Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-9</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2pa-m03MzviEJCPKhJPuqfW6udTcc2eYwb2SM-FBjorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D&md5=62db1c09267fe56d34abef8d5b651750</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500034%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DMetternich%26aufirst%3DR.%26atitle%3DDrug%2520discovery%2520process%2520for%2520kinase%2520Inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D455%26epage%3D459%26doi%3D10.1002%2Fcbic.200500034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-molecule+kinase+inhibitors%3A+an+analysis+of+FDA-approved+drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0ljx_fo4HrlSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%253A%2520an%2520analysis%2520of%2520FDA-approved%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">FDA-approved small-molecule kinase inhibitors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-approved+small-molecule+kinase+inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0ljx_fo4HrlSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-approved%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rüben, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurzlbauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel b-carbolines as potent and selective DYRK1 kinase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0132453</span><span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+R%C3%BCbenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+b-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520b-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Varjosalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keskitalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drogen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurkkala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vichalkovski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstaiger, M.</span><span> </span><span class="NLM_article-title">The protein interaction landscape of the human CMGC kinase group</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.celrep.2013.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23602568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1306-1320&author=M.+Varjosaloauthor=S.+Keskitaloauthor=A.+Van+Drogenauthor=H.+Nurkkalaauthor=A.+Vichalkovskiauthor=R.+Aebersoldauthor=M.+Gstaiger&title=The+protein+interaction+landscape+of+the+human+CMGC+kinase+group&doi=10.1016%2Fj.celrep.2013.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Interaction Landscape of the Human CMGC Kinase Group</span></div><div class="casAuthors">Varjosalo, Markku; Keskitalo, Salla; Van Drogen, Audrey; Nurkkala, Helka; Vichalkovski, Anton; Aebersold, Ruedi; Gstaiger, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1306-1320</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cellular information processing via reversible protein phosphorylation requires tight control of the localization, activity, and substrate specificity of protein kinases, which to a large extent is accomplished by complex formation with other proteins.  Despite their crit. role in cellular regulation and pathogenesis, protein interaction information is available for only a subset of the 518 human protein kinases.  Here we present a global proteomic anal. of complexes of the human CMGC kinase group.  In addn. to subgroup-specific functional enrichment and modularity, the identified 652 high-confidence kinase-protein interactions provide a specific biochem. context for many poorly studied CMGC kinases.  Furthermore, the anal. revealed a kinase-kinase subnetwork and candidate substrates for CMGC kinases.  Finally, the presented interaction proteome uncovered a large set of interactions with proteins genetically linked to a range of human diseases, including cancer, suggesting addnl. routes for analyzing the role of CMGC kinases in controlling human disease pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOh3MUOGE47Vg90H21EOLACvtfcHk0lgn4EH4pLPHOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D&md5=09d13e5b27edff77aeb206ab044e8da6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DVarjosalo%26aufirst%3DM.%26aulast%3DKeskitalo%26aufirst%3DS.%26aulast%3DVan%2BDrogen%26aufirst%3DA.%26aulast%3DNurkkala%26aufirst%3DH.%26aulast%3DVichalkovski%26aufirst%3DA.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DGstaiger%26aufirst%3DM.%26atitle%3DThe%2520protein%2520interaction%2520landscape%2520of%2520the%2520human%2520CMGC%2520kinase%2520group%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1306%26epage%3D1320%26doi%3D10.1016%2Fj.celrep.2013.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirmbter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H.-G.</span><span> </span><span class="NLM_article-title">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">25893</span><span class="NLM_x">–</span> <span class="NLM_lpage">25902</span><span class="refDoi"> DOI: 10.1074/jbc.273.40.25893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1074%2Fjbc.273.40.25893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=9748265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=25893-25902&author=W.+Beckerauthor=Y.+Weberauthor=K.+Wetzelauthor=K.+Eirmbterauthor=F.+J.+Tejedorauthor=H.-G.+Joost&title=Sequence+characteristics%2C+subcellular+localization%2C+and+substrate+specificity+of+DYRK-related+kinases%2C+a+novel+family+of+dual+specificity+protein+kinases&doi=10.1074%2Fjbc.273.40.25893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span></div><div class="casAuthors">Becker, Walter; Weber, Yvonne; Wetzel, Kristiane; Eirmbter, Klaus; Tejedor, Francisco J.; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25893-25902</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">DYRK1 is a dual specificity protein kinase presumably involved in brain development.  The kinase belongs to a new family of protein kinases comprising at least seven mammalian isoforms (DYRK1A, DYRK1B, DYRK1C, DYRK2, DYRK3, DYRK4A, and DYRK4B), the yeast homolog Yak1p, and the Drosophila kinase minibrain (MNB).  In rat tissues, DYRK1A is expressed ubiquitously, whereas transcripts for DYRK1B, DYRK2, DYRK3, and DYRK4 were detected predominantly in testes of adult but not prepuberal rats.  By fluorescence microscopy and subcellular fractionation, a green fluorescent protein (GFP) fusion protein of DYRK1A was found to accumulate in the nucleus of transfected COS-7 and HEK293 cells, whereas GFP-DYRK2 was predominantly detected in the cytoplasm.  DYRK1A exhibited a punctate pattern of GFP fluorescence inside the nucleus and was co-purified with the nuclear matrix.  Anal. of GFP-DYRK1A deletion constructs showed that the nuclear localization of DYRK1A was mediated by its nuclear targeting signal (amino acids 105-139) but that its characteristics subnuclear distribution depended on addnl. N-terminal elements (amino acids 1-104).  When expressed in Escherichia coli, DYRK1A, DYRK2, DYRK3, MNB, and Yak1p catalyzed their autophosphorylation on tyrosine residues.  The kinases differed in their substrate specificity in that DYRK2 and DYRK3, but not DYRK1A and MNB, catalyzed phosphorylation of histone H2B.  The heterogeneity of their subcellular localization and substrate specificity suggests that the kinases are involved in different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Q1vPoFEv4LVg90H21EOLACvtfcHk0lgn4EH4pLPHOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D&md5=4b8029c26149c1ecb9d65baf50dd978d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.40.25893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.40.25893%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DWetzel%26aufirst%3DK.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DJoost%26aufirst%3DH.-G.%26atitle%3DSequence%2520characteristics%252C%2520subcellular%2520localization%252C%2520and%2520substrate%2520specificity%2520of%2520DYRK-related%2520kinases%252C%2520a%2520novel%2520family%2520of%2520dual%2520specificity%2520protein%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D25893%26epage%3D25902%26doi%3D10.1074%2Fjbc.273.40.25893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunckley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, C.</span><span> </span><span class="NLM_article-title">Recent Advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A New avenue for a disease modifying treatment of Alzheimer’s?</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+Advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+A+New+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lgn4EH4pLPHOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520Advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520A%2520New%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dirice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dančík, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B. K.</span><span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human β-cell proliferation</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1660</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span><span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=26953159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8D%C3%ADkauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A stimulates human beta-cell proliferation</span></div><div class="casAuthors">Dirice, Ercument; Walpita, Deepika; Vetere, Amedeo; Meier, Bennett C.; Kahraman, Sevim; Hu, Jiang; Dancik, Vlado; Burns, Sean M.; Gilbert, Tamara J.; Olson, David E.; Clemons, Paul A.; Kulkarni, Rohit N.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1660-1671</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1).  While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle applies to humans, as human β-cells are remarkably resistant to stimulation of division (3,4).  Here, we show that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increase proliferation in rodent and porcine islets (5), strongly and selectively increases human β-cell proliferation in vitro and in vivo.  Remarkably, 5-IT also increased glucose-dependent insulin secretion after prolonged treatment.  Kinome profiling revealed 5-IT to be a potent and selective inhibitor of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) and cell division cycle-like kinase families.  Induction of β-cell proliferation by either 5-IT or harmine, another natural product DYRK1A inhibitor, was suppressed by coincubation with the calcineurin inhibitor FK506, suggesting involvement of DYRK1A and nuclear factor of activated T cells signaling.  Gene expression profiling in whole islets treated with 5-IT revealed induction of proliferation- and cell cycle-related genes, suggesting that true proliferation is induced by 5-IT.  Furthermore, 5-IT promotes β-cell proliferation in human islets grafted under the kidney capsule of NOD-scid IL2Rgnull mice.  These results point to inhibition of DYRK1A as a therapeutic strategy to increase human β-cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLKPVi2wkdrVg90H21EOLACvtfcHk0lh4l2byOEUQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP&md5=c383c8d1f2c1739252ad3cfe4361585c</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258D%25C3%25ADk%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Belgardt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammert, E.</span><span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapies</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1496</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapies&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapies%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span> </span><span class="NLM_article-title">DYRK1A: A potential drug target for multiple Down syndrome neuropathologies</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.2174/18715273113126660186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2174%2F18715273113126660186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=24152332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=26-33&author=W.+Beckerauthor=U.+Soppaauthor=F.+J.+Tejedor&title=DYRK1A%3A+A+potential+drug+target+for+multiple+Down+syndrome+neuropathologies&doi=10.2174%2F18715273113126660186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies</span></div><div class="casAuthors">Becker, Walter; Soppa, Ulf; Tejedor, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Down syndrome (DS), the most common genetic cause of intellectual disability, is caused by the trisomy of chromosome 21.  MNB/DYRK1A (Minibrain/dual specificity tyrosine phosphorylation-regulated kinase 1A) has possibly been the most extensively studied chromosome 21 gene during the last decade due to the remarkable correlation of its functions in the brain with important DS neuropathologies, such as neuronal deficits, dendrite atrophy, spine dysgenesis, precocious Alzheimer's-like neurodegeneration, and cognitive deficits.  MNB/DYRK1A has become an attractive drug target because increasing evidence suggests that its overexpression may induce DS-like neurobiol. alterations, and several small-mol. inhibitors of its protein kinase activity are available.  Here, we summarize the functional complexity of MNB/DYRK1A from a DS-research perspective, paying particular attention to the capacity of different MNB/DYRK1A inhibitors to reverse the neurobiol. alterations caused by the increased activity of MNB/DYRK1A in exptl. models.  Finally, we discuss the advantages and drawbacks of possible MNB/DYRK1A-based therapeutic strategies that result from the functional, mol., and pharmacol. complexity of MNB/DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaG-2GxDUKR7Vg90H21EOLACvtfcHk0lh4l2byOEUQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D&md5=4b9c141d30bbf23f35f73b63e31f3e65</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.2174%2F18715273113126660186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715273113126660186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26atitle%3DDYRK1A%253A%2520A%2520potential%2520drug%2520target%2520for%2520multiple%2520Down%2520syndrome%2520neuropathologies%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D26%26epage%3D33%26doi%3D10.2174%2F18715273113126660186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=22918246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span></div><div class="casAuthors">Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation.  Members of the DYRK family phosphorylate many substrates, including crit. regulators of the cell cycle.  A recent report revealed that human DYRK2 actas as a neg. regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degrdn.  Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins.  DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degrdn. and stabilizing p27Kip1.  The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development.  This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnd37_01t3rVg90H21EOLACvtfcHk0lh4l2byOEUQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D&md5=df11959806a3cd7029023b270f74800f</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ionescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span><span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0lhUcyuFD2YsLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+Molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0lhUcyuFD2YsLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520Molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/DYRK1B in cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1002/jcb.21451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1002%2Fjcb.21451" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=274-279&author=E.+Friedman&title=Mirk%2FDYRK1B+in+cancer&doi=10.1002%2Fjcb.21451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjcb.21451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.21451%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDYRK1B%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D274%26epage%3D279%26doi%3D10.1002%2Fjcb.21451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lgqV89qOUPu0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eY4Hw6vdFcP-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eY4Hw6vdFcP-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberholzer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9312</span><span class="NLM_x">–</span> <span class="NLM_lpage">9330</span><span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0ljWWe9FINClQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominique, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6610</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.bmcl.2013.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.+C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615%26doi%3D10.1016%2Fj.bmcl.2013.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Falke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loäec, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu Jhaisha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">10-Iodo-11<i>H</i>-indolo[3,2-<i>c</i>]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3143</span><span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Lo%C3%A4ecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0ljWWe9FINClQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLo%25C3%25A4ec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiéry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Novel 9-oxo-thiazolo[5,4-<i>f</i>]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.ejmech.2007.09.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1469-1477&author=C.+Log%C3%A9author=A.+Testardauthor=V.+Thi%C3%A9ryauthor=O.+Lozachauthor=M.+Blairvacqauthor=J.-M.+Robertauthor=L.+Meijerauthor=T.+Besson&title=Novel+9-oxo-thiazolo%5B5%2C4-f%5Dquinazoline-2-carbonitrile+derivatives+as+dual+cyclin-dependent+kinase+1+%28CDK1%29%2Fglycogen+synthase+kinase-3+%28GSK-3%29+inhibitors%3A+synthesis%2C+biological+evaluation+and+molecular+modeling+studies&doi=10.1016%2Fj.ejmech.2007.09.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DTestard%26aufirst%3DA.%26aulast%3DThi%25C3%25A9ry%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DNovel%25209-oxo-thiazolo%255B5%252C4-f%255Dquinazoline-2-carbonitrile%2520derivatives%2520as%2520dual%2520cyclin-dependent%2520kinase%25201%2520%2528CDK1%2529%252Fglycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1469%26epage%3D1477%26doi%3D10.1016%2Fj.ejmech.2007.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Testard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiéry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Thiazolo[5,4-<i>f</i>]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3419</span><span class="NLM_x">–</span> <span class="NLM_lpage">3423</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.bmcl.2006.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3419-3423&author=A.+Testardauthor=C.+Log%C3%A9author=B.+L%C3%A9gerauthor=J.-M.+Robertauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=V.+Thi%C3%A9ryauthor=T.+Besson&title=Thiazolo%5B5%2C4-f%5Dquinazolin-9-ones%2C+inhibitors+of+glycogen+synthase+kinase-3&doi=10.1016%2Fj.bmcl.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DTestard%26aufirst%3DA.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DL%25C3%25A9ger%26aufirst%3DB.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThi%25C3%25A9ry%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DThiazolo%255B5%252C4-f%255Dquinazolin-9-ones%252C%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3419%26epage%3D3423%26doi%3D10.1016%2Fj.bmcl.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Deau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levacher, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Convenient one-pot synthesis of <i>N</i><sup>3</sup>-substituted pyrido[2,3-<i>d</i>]-, pyrido[3,4-<i>d</i>]-, pyrido[4,3-<i>d</i>]-pyrimidin-4(3<i>H</i>)-ones, and quinazolin-4(3<i>H</i>)-ones analogs</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3518</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2013.04.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.tetlet.2013.04.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2rurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=3518-3521&author=E.+Deauauthor=D.+H%C3%A9douauthor=E.+Chossonauthor=V.+Levacherauthor=T.+Besson&title=Convenient+one-pot+synthesis+of+N3-substituted+pyrido%5B2%2C3-d%5D-%2C+pyrido%5B3%2C4-d%5D-%2C+pyrido%5B4%2C3-d%5D-pyrimidin-4%283H%29-ones%2C+and+quinazolin-4%283H%29-ones+analogs&doi=10.1016%2Fj.tetlet.2013.04.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient one-pot synthesis of N3-substituted pyrido[2,3-d]-, pyrido[3,4-d]-, pyrido[4,3-d]-pyrimidin-4(3H)-ones, and quinazolin-4(3H)-ones analogs</span></div><div class="casAuthors">Deau, Emmanuel; Hedou, Damien; Chosson, Elizabeth; Levacher, Vincent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3518-3521</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A convenient microwave-assisted one-pot sequential synthesis provided access to novel pyridopyrimidin-4-(3H)-ones in good to excellent yields.  Anthranilic acid, 2- and 4-aminonicotinic acids, and 3-aminoisonicotinic acid were quant. converted into the analogous amidinoesters which undergo rapid cyclization in the presence of an amine.  E.g., irradn. of anthranilic acid and DMFDMA in DMF for 15 min., followed by addn. of PrNH2 and AcOH and another 15 min. of irradn. gave 87% N3-alkylated quinazolin-4-one deriv. (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKCaSGnvIbF7Vg90H21EOLACvtfcHk0ljkYYnRolZ4DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2rurk%253D&md5=07aa0dcfb41c5b51d5b9e4c98cea9df2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.04.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.04.096%26sid%3Dliteratum%253Aachs%26aulast%3DDeau%26aufirst%3DE.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DChosson%26aufirst%3DE.%26aulast%3DLevacher%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DConvenient%2520one-pot%2520synthesis%2520of%2520N3-substituted%2520pyrido%255B2%252C3-d%255D-%252C%2520pyrido%255B3%252C4-d%255D-%252C%2520pyrido%255B4%252C3-d%255D-pyrimidin-4%25283H%2529-ones%252C%2520and%2520quinazolin-4%25283H%2529-ones%2520analogs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D3518%26epage%3D3521%26doi%3D10.1016%2Fj.tetlet.2013.04.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Leblond, B.; Casagrande, A.-S.; Désiré, L.; Foucourt, A.; Besson, T.</span><span> </span><span class="NLM_article-title">DYRK1 inhibitors and uses thereof</span>. Patent WO 2013026806,<span class="NLM_x"> </span><span class="NLM_year">2013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Leblond&author=A.-S.+Casagrande&author=L.+D%C3%A9sir%C3%A9&author=A.+Foucourt&author=T.+Besson&title=DYRK1+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DDYRK1%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref24_2"><span>; <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">390018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%3BChem.+Abstr.+2013%2C+158%2C+390018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref24_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2013%26volume%3D158%26spage%3D390018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-<i>f</i>]quinazolines as DYRK1A inhibitors, Part I</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">15546</span><span class="NLM_x">–</span> <span class="NLM_lpage">15571</span><span class="refDoi"> DOI: 10.3390/molecules191015546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fmolecules191015546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25268714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15546-15571&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=L.+D%C3%A9sir%C3%A9author=A.-S.+Casagrandeauthor=B.+Leblondauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+Part+I&doi=10.3390%2Fmolecules191015546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I</span></div><div class="casAuthors">Foucourt, Alicia; Heou, Damien; Dubouilh-Benard, Carole; Desire, Laurent; Casagrande, Anne-Sophie; Leblond, Bertrand; Loaec, Nadege; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15546-15571, 26 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a library of novel 6,6,5-tricyclic thiazolo[5,4-f] quinazolines (forty mols.) I [R1 = 4-methoxyphenyl, 3,4-methylendioxyphenyl, 4-bromo-2-fluorophenyl, 3-chloro-2-fluorophenyl, 3,4-methylendioxy-5-bromophenyl; R2 = N≡C, H3CO(HN)C, H2N(O)C, (CH3)2N(HN)C, H5C6H2C, etc.] was achieved mainly under microwave irradn.  Dimroth rearrangement and 4,5-dichloro-1,2,3-dithiazolium chloride (Appel salt) chem. were assocd. for the synthesis of a novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile a versatile mol. platform for the synthesis of various bioactive derivs.  Kinase inhibition of the final compds. was evaluated on a panel of four Ser/Thr kinases (DYRK1A, CDK5, CK1 and GSK3) chosen for their strong implications in various regulation processes, esp. Alzheimer's disease (AD) and the results of this preliminary screening, thiazolo[5,4-f]quinazoline scaffolds constitutes a promising source of inspiration for the synthesis of novel bioactive mols.  Among the compds. of this novel chemolibrary, I [R1 = 4-methoxyphenyl, 3,4-methylendioxyphenyl, 4-bromo-2-fluorophenyl; R2 = H3CO(HN)C] inhibited DYRK1A with IC50 values ranging in the double-digit nanomolar range (40, 47 and 50 nM, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomAJWdE26QF7Vg90H21EOLACvtfcHk0lhyaAg4uDzNGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLjO&md5=10eb0ad823d50a9fac328cc8ee7dbb4a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015546%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520Part%2520I%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15546%26epage%3D15571%26doi%3D10.3390%2Fmolecules191015546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-<i>f</i>]quinazolines as DYRK1A inhibitors, Part II</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">15411</span><span class="NLM_x">–</span> <span class="NLM_lpage">15439</span><span class="refDoi"> DOI: 10.3390/molecules191015411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fmolecules191015411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25264830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15411-15439&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=A.+Girardauthor=T.+Taverneauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=B.+Leblondauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+Part+II&doi=10.3390%2Fmolecules191015411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span></div><div class="casAuthors">Foucourt, Alicia; Hedou, Damien; Dubouilh-Benard, Carole; Girard, Angelique; Taverne, Thierry; Casagrande, Anne-Sophie; Desire, Laurent; Leblond, Bertrand; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15411-15439, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a focused library (forty mols.) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines I (R = 4-MeOC6H4, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, etc.) was achieved mainly under microwave irradn.  A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile was used as a versatile mol. platform for the synthesis of various derivs.  Kinase inhibition, of the obtained final compds., was evaluated on a panel of two kinases (DYRK1A/1B) together with some known ref. DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41).  Compd. IC50 values were obtained and compared.  Five of the novel thiazolo[5,4-f]quinazoline derivs. prepd., I (R = 2,4-Cl2C6H3, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, 2,4-F2C6H3, 4-MeC6H4) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date.  DYRK1A/1B kinases are known to be involved in the regulation of various mol. pathways assocd. with oncol., neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing.  The compds. described in this communication constitute a highly potent set of novel mol. probes to evaluate the biol./pharmacol. of DYR1A/1B in such diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxocRjJkBbrVg90H21EOLACvtfcHk0lhyaAg4uDzNGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM&md5=cefa4032d967cd704a189f3a62a1738d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015411%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520Part%2520II%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15411%26epage%3D15439%26doi%3D10.3390%2Fmolecules191015411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Coutadeur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyamine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalonde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pando, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span> </span><span class="NLM_article-title">A Novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: Effect on tau and amyloid pathologies in vitro</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.-S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=A+Novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+Effect+on+tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0lhyaAg4uDzNGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3DA%2520Novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Effect%2520on%2520tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+Molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0liPkrEuDdPYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520Molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pando, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span> </span><span class="NLM_article-title">3D multicellular pancreatic cancer spheroids as drug screening tool for pharmacological evaluation of EHT 5372 and other Mirk/DYRK1B inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2620</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-2620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1158%2F1538-7445.AM2014-2620" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2620&author=A.-S.+Casagrandeauthor=F.+Bachelotauthor=E.+Throoauthor=F.+Mah%C3%A9author=B.+Leblondauthor=T.+Bessonauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=3D+multicellular+pancreatic+cancer+spheroids+as+drug+screening+tool+for+pharmacological+evaluation+of+EHT+5372+and+other+Mirk%2FDYRK1B+inhibitors&doi=10.1158%2F1538-7445.AM2014-2620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-2620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-2620%26sid%3Dliteratum%253Aachs%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DBachelot%26aufirst%3DF.%26aulast%3DThroo%26aufirst%3DE.%26aulast%3DMah%25C3%25A9%26aufirst%3DF.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3D3D%2520multicellular%2520pancreatic%2520cancer%2520spheroids%2520as%2520drug%2520screening%2520tool%2520for%2520pharmacological%2520evaluation%2520of%2520EHT%25205372%2520and%2520other%2520Mirk%252FDYRK1B%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2620%26doi%3D10.1158%2F1538-7445.AM2014-2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.18632/genesandcancer.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25352950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOitbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=337-347&author=X.+Dengauthor=E.+Friedman&title=Mirk+kinase+inhibition+blocks+the+in+vivo+growth+of+pancreatic+cancer+cells&doi=10.18632%2Fgenesandcancer.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells</span></div><div class="casAuthors">Deng, Xiaobing; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">337-347, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">The Mirk/dyrk1B gene is upregulated and sometimes amplified in pancreatic ductal carcinomas.  In poor microenvironmental conditions Mirk mediates cell survival by maintaining cancer cells in a largely quiescent, noncycling state and by decreasing toxic ROS levels through maintaining expression of a series of antioxidant genes.  Premature entry into cycle, increased ROS levels, DNA damage, and apoptosis follow Mirk kinase depletion or inhibition.  Mirk kinase inhibitor EHT5372 treated Panc1 spheroids lost quiescence markers coincident with an increase in cyclin A showing entry into cycle, and exhibited DNA damage, apoptosis and smaller size.  EHT5372 treatment in vivo led to an increased fraction of Ki67 pos., cycling cells in Panc1 xenografts whose size was reduced.  Pdx-1-cre LSL/KrasG12D/Ink4a/Arf null B6 mice always develop pancreatic cancer, allowing only 30% survival by 8 wk, while each of the Mirk kinase inhibitor treated mice survived 8 wk.  Mirk inhibition led to a roughly four-fold increase in tumor αSMA-pos. fibroblasts and large stromal collagen-rich infiltrates in the pancreas that can restrain tumor growth.  The mTOR inhibitor RAD001 alone, or together with EHT5372, reduced pancreatic cancer size 30-fold, while the drug combination reduced the no. of microscopic tumor foci 2-fold compared to RAD001 alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJINa17jGfO7Vg90H21EOLACvtfcHk0liPkrEuDdPYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOitbzP&md5=7b2b18b0514ba83873d3cf587fdc9368</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.29%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520kinase%2520inhibition%2520blocks%2520the%2520in%2520vivo%2520growth%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D337%26epage%3D347%26doi%3D10.18632%2Fgenesandcancer.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk kinase inhibition targets ovarian cancer ascites</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.18632/genesandcancer.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25061503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=201-211&author=X.+Dengauthor=J.+Huauthor=M.+J.+Cunninghamauthor=E.+Friedman&title=Mirk+kinase+inhibition+targets+ovarian+cancer+ascites&doi=10.18632%2Fgenesandcancer.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk kinase inhibition targets ovarian cancer ascites</span></div><div class="casAuthors">Deng, Xiaobing; Hu, Jing; Cunningham, Mary J.; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">The Mirk/dyrk1B gene is commonly amplified or upregulated in ovarian cancers, and Mirk is an active kinase in these cancers.  Mirk mediates cancer cell survival by decreasing toxic ROS levels through maintaining expression of a series of antioxidant genes, possibly through its transcriptional activator functions.  Mirk has the unusual property of being most active in quiescent cancer cells because of marked transcriptional downregulation by Akt/mTOR signaling and by MEK/erk signaling in cycling cells.  Metastatic ovarian cancer cells form ascites, non-adherent multicellular aggregates floating within the peritoneal fluid.  Most ascites cancer cells are in a reversible quiescent, dormant state, suggesting that Mirk might be expressed in these quiescent cells and thus a therapeutic target.  The current studies show that ovarian cancer cell line spheroids that mimic ascites cancer spheroids were largely quiescent in G0/G1, and enriched in Mirk and the quiescence proteins, p130/Rb2 and the CDKI p27.  Mirk kinase inhibition in spheroids made from established cell lines and in patient-derived ascites cancer cell spheroids reduced spheroid vol., disrupted spheroid structure to single cells, increased apoptosis, and decreased cell nos.  Earlier studies had shown that the mTOR inhibitor RAD001 increased transcription of the Mirk/dyrk1B gene, so treatments combined RAD001 with the most active Mirk kinase inhibitor.  The no. of ascites cells from 9 patients was reduced a similar amt. by cisplatin, Mirk kinase inhibition or RAD001, but reduced substantially more, about 90%, by concurrent treatment with both the Mirk kinase inhibitor EHT5372 and RAD001.  Addn. of RAD001 increased the amt. of toxic ROS induced by Mirk kinase inhibition.  Two ascites samples taken one month apart gave similar drug responses, showing reproducibility of the techniques.  Thus Mirk/dyrk1B kinase may be a therapeutic target in ovarian cancer ascites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcPoXXar7T7Vg90H21EOLACvtfcHk0liPkrEuDdPYZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSktbvI&md5=a2f52e94abce9bcd3665fbefc75428b0</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.19%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DM.%2BJ.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520kinase%2520inhibition%2520targets%2520ovarian%2520cancer%2520ascites%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D201%26epage%3D211%26doi%3D10.18632%2Fgenesandcancer.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.18632/genesandcancer.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=24955215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=22-30&author=X.+Dengauthor=S.+E.+Mercerauthor=C.+Y.+Sunauthor=E.+Friedman&title=The+normal+function+of+the+cancer+kinase+Mirk%2Fdyrk1B+is+to+reduce+reactive+oxygen+species&doi=10.18632%2Fgenesandcancer.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species</span></div><div class="casAuthors">Deng, Xiaobing; Mercer, Stephen E.; Sun, Chi-Yu; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Mirk kinase is a gene upregulated and sometimes amplified in pancreatic cancers and in ovarian cancers, but expressed at very low levels in most normal diploid cells except for skeletal muscle.  The muscle cell function of Mirk kinase selected for by cancer cells is unknown.  It is now shown that Mirk protein is expressed at low levels and is largely nuclear in cycling skeletal muscle C2C12 myoblasts, but is translocated to the cytoplasm and upregulated when myoblasts initiate differentiation, as shown by immunofluorescence staining and by cell fractionation.  Either Mirk depletion or Mirk kinase inhibition increased ROS levels in cycling C2C12 myoblasts.  However, Mirk protein is localized in the cytoplasm of mature muscle fibers, specifically in the fast twitch fibers of human skeletal muscle where toxic ROS levels are generated by muscle contraction.  C2C12 myoblasts at high d. in differentiation media fuse to form differentiated postmitotic myotubes that can contract.  A Mirk kinase inhibitor induced a dose-dependent increase in ROS in this model for fast twitch fibers of human skeletal muscle.  Efficient Mirk depletion in SU86.86 pancreatic cancer cells by an inducible shRNA decreased expression of eight antioxidant genes.  Thus both cancer cells and differentiated myotubes utilize Mirk kinase to relieve oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4KkpxAfgG7Vg90H21EOLACvtfcHk0lh2U1wo_bqDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWqs7nN&md5=8d369a6ce403ecf1a3ec1429e7562f8b</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.1%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DMercer%26aufirst%3DS.%2BE.%26aulast%3DSun%26aufirst%3DC.%2BY.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DThe%2520normal%2520function%2520of%2520the%2520cancer%2520kinase%2520Mirk%252Fdyrk1B%2520is%2520to%2520reduce%2520reactive%2520oxygen%2520species%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D22%26epage%3D30%26doi%3D10.18632%2Fgenesandcancer.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thompson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhansali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolzenburg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. D.</span><span> </span><span class="NLM_article-title">DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1084/jem.20150002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1084%2Fjem.20150002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=953-970&author=B.+Thompsonauthor=R.+Bhansaliauthor=L.+Dieboldauthor=D.+E.+Cookauthor=L.+Stolzenburgauthor=A.-S.+Casagrandeauthor=T.+Bessonauthor=B.+Leblondauthor=L.+D%C3%A9sir%C3%A9author=S.+Malingeauthor=J.+D.+Crispino&title=DYRK1A+controls+the+transition+from+proliferation+to+quiescence+during+lymphoid+development+by+destabilizing+Cyclin+D3&doi=10.1084%2Fjem.20150002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150002%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DB.%26aulast%3DBhansali%26aufirst%3DR.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DCook%26aufirst%3DD.%2BE.%26aulast%3DStolzenburg%26aufirst%3DL.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DDYRK1A%2520controls%2520the%2520transition%2520from%2520proliferation%2520to%2520quiescence%2520during%2520lymphoid%2520development%2520by%2520destabilizing%2520Cyclin%2520D3%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D953%26epage%3D970%26doi%3D10.1084%2Fjem.20150002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Stotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span> </span><span class="NLM_article-title">DYRK1A inhibition as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.4155%2Ffmc-2016-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=27073990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=681-693&author=S.+Stotaniauthor=F.+Giordanettoauthor=F.+Medda&title=DYRK1A+inhibition+as+potential+treatment+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2016-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition as potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Stotani, Silvia; Giordanetto, Fabrizio; Medda, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">681-696</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In total, 47,500,000 people worldwide are affected by dementia and this no. is estd. to double by 2030 and triple within 2050 resulting in a huge burden on public health.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of dementia, accounting for 60-70% of all the cases.  The cause of AD is still poorly understood but several brain abnormalities (e.g., loss of neuronal connections and neuronal death) have been identified in affected patients.  In addn. to the accumulation of β-amyloid plaques in the brain tissue, aberrant phosphorylation of tau proteins has proved to increase neuronal death.  DYRK1A phosphorylates tau on 11 different Ser/Thr residues, resulting in the formation of aggregates called 'neurofibrillary tangles' which, together with amyloid plaques, could be responsible for dementia, neuronal degeneration and cell death.  Small mol. inhibition of DYRK1A could thus represent an interesting approach toward the treatment of Alzheimer's and other neurodegenerative diseases.  Herein we review the current progress in the identification and development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIkkQdSVqce7Vg90H21EOLACvtfcHk0lh2U1wo_bqDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D&md5=7f90e6dc11edc4d395371d7ad07460d7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0013%26sid%3Dliteratum%253Aachs%26aulast%3DStotani%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMedda%26aufirst%3DF.%26atitle%3DDYRK1A%2520inhibition%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D681%26epage%3D693%26doi%3D10.4155%2Ffmc-2016-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/Dyrk1B kinase in ovarian cancer</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5575</span><span class="refDoi"> DOI: 10.3390/ijms14035560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fijms14035560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23528858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=5560-5575&author=E.+Friedman&title=Mirk%2FDyrk1B+kinase+in+ovarian+cancer&doi=10.3390%2Fijms14035560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk/dyrk1B kinase in ovarian cancer</span></div><div class="casAuthors">Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5560-5575</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Mirk/dyrk1B kinase is expressed in about 75% of resected human ovarian cancers and in most ovarian cancer cell lines with amplification in the OVCAR3 line.  Mirk (minibrain-related kinase) is a member of the Minibrain/dyrk family of related serine/threonine kinases.  Mirk maintains cells in a quiescent state by stabilizing the CDK inhibitor p27 and by inducing the breakdown of cyclin D isoforms.  Mirk also stabilizes the DREAM complex, which maintains G0 quiescence by sequestering transcription factors needed to enter cycle.  By entering a quiescent state, tumor cells can resist the nutrient deficiencies, hypoxic and acidic conditions within the tumor mass.  Mirk maintains the viability of quiescent ovarian cancer cells by reducing intracellular levels of reactive oxygen species.  CDKN2A-neg. ovarian cancer cells treated with a Mirk kinase inhibitor escaped G0/G1 quiescence, entered cycle with high ROS levels and underwent apoptosis.  The ROS scavenger N-acetyl cysteine reduced the extent of cancer cell loss.  In contrast, the Mirk kinase inhibitor slightly reduced the fraction of G0 quiescent diploid epithelial cells and fibroblasts, and the majority of the cells pushed into cycle accumulated in G2 + M.  Apoptotic sub-G0/G1 cells were not detected.  Thus, normal cells were spared because of their expression of CDK inhibitors that blocked unregulated cycling and Mirk kinase inhibitor-treated normal diploid cells were about as viable as untreated controls.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonJpdV3yRq8bVg90H21EOLACvtfcHk0lh2U1wo_bqDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gjtrc%253D&md5=7514fe15aa23d30516abcc7452ae116c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fijms14035560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14035560%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDyrk1B%2520kinase%2520in%2520ovarian%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D5560%26epage%3D5575%26doi%3D10.3390%2Fijms14035560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/dyrk1B kinase is upregulated following inhibition of mTOR</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1968</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1093/carcin/bgu058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1093%2Fcarcin%2Fbgu058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1968-1976&author=X.+Dengauthor=J.+Huauthor=D.+Z.+Ewtonauthor=E.+Friedman&title=Mirk%2Fdyrk1B+kinase+is+upregulated+following+inhibition+of+mTOR&doi=10.1093%2Fcarcin%2Fbgu058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgu058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgu058%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252Fdyrk1B%2520kinase%2520is%2520upregulated%2520following%2520inhibition%2520of%2520mTOR%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D1968%26epage%3D1976%26doi%3D10.1093%2Fcarcin%2Fbgu058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24','ref24_2'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Martin Schröder, Alex N. Bullock, Oleg Fedorov, Franz Bracher, Apirat Chaikuad, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10224-10234. <a href="https://doi.org/10.1021/acs.jmedchem.0c00898" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDFG-1%252BResidue%252BControls%252BInhibitor%252BBinding%252BMode%252Band%252BAffinity%25252C%252BProviding%252Ba%252BBasis%252Bfor%252BRational%252BDesign%252Bof%252BKinase%252BInhibitor%252BSelectivity%26aulast%3DSchr%25C3%25B6der%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D27082020%26date%3D12082020%26volume%3D63%26issue%3D18%26spage%3D10224%26epage%3D10234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jade Fogha, Julien Diharce, Alan Obled, Samia Aci-Sèche, <span class="NLM_string-name hlFld-ContribAuthor">Pascal Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Analysis of Crystallization Additives for the Identification of New Allosteric Sites. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (5)
                                     , 2114-2122. <a href="https://doi.org/10.1021/acsomega.9b02697" title="DOI URL">https://doi.org/10.1021/acsomega.9b02697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b02697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b02697%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DComputational%252BAnalysis%252Bof%252BCrystallization%252BAdditives%252Bfor%252Bthe%252BIdentification%252Bof%252BNew%252BAllosteric%252BSites%26aulast%3DFogha%26aufirst%3DJade%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D21082019%26date%3D21112019%26date%3D03022020%26volume%3D5%26issue%3D5%26spage%3D2114%26epage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dnyandev
B. Jarhad, Karishma K. Mashelkar, Hong-Rae Kim, Minsoo Noh, <span class="NLM_string-name hlFld-ContribAuthor">Lak Shin Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9791-9810. <a href="https://doi.org/10.1021/acs.jmedchem.8b00185" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00185%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Specificity%252BTyrosine%252BPhosphorylation-Regulated%252BKinase%252B1A%252B%252528DYRK1A%252529%252BInhibitors%252Bas%252BPotential%252BTherapeutics%26aulast%3DJarhad%26aufirst%3DDnyandev%2BB.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05022018%26date%3D20072018%26date%3D09072018%26volume%3D61%26issue%3D22%26spage%3D9791%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Czarna, Jinhua Wang, Diana Zelencova, Yao Liu, Xianming Deng, Hwan Geun Choi, Tinghu Zhang, Wenjun Zhou, Jae Won Chang, Hanne Kildalsen, Ole Morten Seternes, Nathanael S. Gray, Richard A. Engh, <span class="NLM_string-name hlFld-ContribAuthor">Ulli Rothweiler</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7560-7572. <a href="https://doi.org/10.1021/acs.jmedchem.7b01847" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01847%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BScaffolds%252Bfor%252BDual%252BSpecificity%252BTyrosine-Phosphorylation-Regulated%252BKinase%252B%252528DYRK1A%252529%252BInhibitors%26aulast%3DCzarna%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D27122017%26date%3D23082018%26date%3D10082018%26volume%3D61%26issue%3D17%26spage%3D7560%26epage%3D7572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Athena F.  Phoa</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Josep S.  Font</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Brett W.  Stringer</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, and <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 2052-2070. <a href="https://doi.org/10.1021/acs.jmedchem.6b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BOptimization%252Band%252BPharmacological%252BEvaluation%252Bof%252BInhibitors%252BTargeting%252BDual-Specificity%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRK%252529%252Band%252BCDC-like%252Bkinases%252B%252528CLK%252529%252Bin%252BGlioblastoma%26aulast%3DZhou%26aufirst%3DQingqing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D16122016%26date%3D28022017%26date%3D09032017%26date%3D16022017%26volume%3D60%26issue%3D5%26spage%3D2052%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul S.  Bhansali</span>, <span class="hlFld-ContribAuthor ">Malini  Rammohan</span>, <span class="hlFld-ContribAuthor ">Paul  Lee</span>, <span class="hlFld-ContribAuthor ">Anouchka P.  Laurent</span>, <span class="hlFld-ContribAuthor ">Qiang  Wen</span>, <span class="hlFld-ContribAuthor ">Praveen  Suraneni</span>, <span class="hlFld-ContribAuthor ">Bon Ham  Yip</span>, <span class="hlFld-ContribAuthor ">Yi-Chien  Tsai</span>, <span class="hlFld-ContribAuthor ">Silvia  Jenni</span>, <span class="hlFld-ContribAuthor ">Beat  Bornhauser</span>, <span class="hlFld-ContribAuthor ">Aurélie  Siret</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Alexandra  Pacheco-Benichou</span>, <span class="hlFld-ContribAuthor ">Ethan  Harris</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Young Ah  Goo</span>, <span class="hlFld-ContribAuthor ">Nobuko  Hijiya</span>, <span class="hlFld-ContribAuthor ">Maria  Vilenchik</span>, <span class="hlFld-ContribAuthor ">Shai  Izraeli</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Bourquin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Malinge</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2021,</strong> <em>131 </em>
                                    (1)
                                     <a href="https://doi.org/10.1172/JCI135937" title="DOI URL">https://doi.org/10.1172/JCI135937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI135937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI135937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DDYRK1A%252Bregulates%252BB%252Bcell%252Bacute%252Blymphoblastic%252Bleukemia%252Bthrough%252Bphosphorylation%252Bof%252BFOXO1%252Band%252BSTAT3%26aulast%3DBhansali%26aufirst%3DRahul%2BS.%26date%3D2021%26date%3D2021%26volume%3D131%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasudha  Tandon</span>, <span class="hlFld-ContribAuthor ">Laureano  de la Vega</span>, <span class="hlFld-ContribAuthor ">Sourav  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging roles of DYRK2 in cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100233. <a href="https://doi.org/10.1074/jbc.REV120.015217" title="DOI URL">https://doi.org/10.1074/jbc.REV120.015217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.REV120.015217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.REV120.015217%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DEmerging%252Broles%252Bof%252BDYRK2%252Bin%252Bcancer%26aulast%3DTandon%26aufirst%3DVasudha%26date%3D2021%26volume%3D296%26spage%3D100233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Octavio  Silva-García</span>, <span class="hlFld-ContribAuthor ">Ricarda  Cortés-Vieyra</span>, <span class="hlFld-ContribAuthor ">Francisco N.  Mendoza-Ambrosio</span>, <span class="hlFld-ContribAuthor ">Guillermo  Ramírez-Galicia</span>, <span class="hlFld-ContribAuthor ">Víctor M.  Baizabal-Aguirre</span>. </span><span class="cited-content_cbyCitation_article-title">GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (12)
                                     , 1683. <a href="https://doi.org/10.3390/biom10121683" title="DOI URL">https://doi.org/10.3390/biom10121683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10121683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10121683%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DGSK3%2525CE%2525B1%25253A%252BAn%252BImportant%252BParalog%252Bin%252BNeurodegenerative%252BDisorders%252Band%252BCancer%26aulast%3DSilva-Garc%25C3%25ADa%26aufirst%3DOctavio%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D12%26spage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wayland  Yeung</span>, <span class="hlFld-ContribAuthor ">Zheng  Ruan</span>, <span class="hlFld-ContribAuthor ">Natarajan  Kannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging roles of the αC‐β4 loop in protein kinase structure, function, evolution, and disease. </span><span class="cited-content_cbyCitation_journal-name">IUBMB Life</span><span> <strong>2020,</strong> <em>72 </em>
                                    (6)
                                     , 1189-1202. <a href="https://doi.org/10.1002/iub.2253" title="DOI URL">https://doi.org/10.1002/iub.2253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/iub.2253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fiub.2253%26sid%3Dliteratum%253Aachs%26jtitle%3DIUBMB%2520Life%26atitle%3DEmerging%252Broles%252Bof%252Bthe%252B%2525CE%2525B1C%2525E2%252580%252590%2525CE%2525B24%252Bloop%252Bin%252Bprotein%252Bkinase%252Bstructure%25252C%252Bfunction%25252C%252Bevolution%25252C%252Band%252Bdisease%26aulast%3DYeung%26aufirst%3DWayland%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D6%26spage%3D1189%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">勇  王</span>. </span><span class="cited-content_cbyCitation_article-title">The Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 1A and the Advances of Its Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>08 </em>
                                    (02)
                                     , 38-50. <a href="https://doi.org/10.12677/HJMCe.2020.82006" title="DOI URL">https://doi.org/10.12677/HJMCe.2020.82006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2020.82006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2020.82006%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDual-Specificity%252BTyrosine%252BPhosphorylation%252BRegulated%252BKinase%252B1A%252Band%252Bthe%252BAdvances%252Bof%252BIts%252BInhibitors%26aulast%3D%25E7%258E%258B%26aufirst%3D%25E5%258B%2587%26date%3D2020%26volume%3D08%26issue%3D02%26spage%3D38%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Elie</span>, <span class="hlFld-ContribAuthor ">Omid  Feizbakhsh</span>, <span class="hlFld-ContribAuthor ">Nathalie  Desban</span>, <span class="hlFld-ContribAuthor ">Béatrice  Josselin</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Amandine  Bescond</span>, <span class="hlFld-ContribAuthor ">Julien  Duez</span>, <span class="hlFld-ContribAuthor ">Xavier  Fant</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Dominique  Marie</span>, <span class="hlFld-ContribAuthor ">Matthieu  Place</span>, <span class="hlFld-ContribAuthor ">Sami  Ben Salah</span>, <span class="hlFld-ContribAuthor ">Agnes  Chartier</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Fabrice  Carles</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>. </span><span class="cited-content_cbyCitation_article-title">Design of new disubstituted imidazo[1,2-
              b
              ]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1840-1853. <a href="https://doi.org/10.1080/14756366.2020.1825408" title="DOI URL">https://doi.org/10.1080/14756366.2020.1825408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1825408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1825408%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Bnew%252Bdisubstituted%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252Bderivatives%252Bas%252Bselective%252BHaspin%252Binhibitors.%252BSynthesis%25252C%252Bbinding%252Bmode%252Band%252Banticancer%252Bbiological%252Bevaluation%26aulast%3DElie%26aufirst%3DJonathan%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1840%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Florence  Couly</span>, <span class="hlFld-ContribAuthor ">Rahul  Bhansali</span>, <span class="hlFld-ContribAuthor ">Malini  Rammohan</span>, <span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (4)
                                     , 185. <a href="https://doi.org/10.3390/ph12040185" title="DOI URL">https://doi.org/10.3390/ph12040185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12040185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12040185%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBiological%252BCharacterization%252Bof%252B8-Cyclopropyl-2-%252528pyridin-3-yl%252529thiazolo%25255B5%25252C4-f%25255Dquinazolin-9%2525288H%252529-one%25252C%252Ba%252BPromising%252BInhibitor%252Bof%252BDYRK1A%26aulast%3DFruit%26aufirst%3DCorinne%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Lechner</span>, <span class="hlFld-ContribAuthor ">Maren  Flaßhoff</span>, <span class="hlFld-ContribAuthor ">Hannes  Falke</span>, <span class="hlFld-ContribAuthor ">Lutz  Preu</span>, <span class="hlFld-ContribAuthor ">Nadége  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Conrad  Kunick</span>. </span><span class="cited-content_cbyCitation_article-title">[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4090. <a href="https://doi.org/10.3390/molecules24224090" title="DOI URL">https://doi.org/10.3390/molecules24224090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224090%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%25255Bb%25255D-Annulated%252BHalogen-Substituted%252BIndoles%252Bas%252BPotential%252BDYRK1A%252BInhibitors%26aulast%3DLechner%26aufirst%3DChristian%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florence  Couly</span>, <span class="hlFld-ContribAuthor ">Marine  Harari</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Laetitia  Bailly</span>, <span class="hlFld-ContribAuthor ">Emilie  Petit</span>, <span class="hlFld-ContribAuthor ">Julien  Diharce</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Kinase Inhibitors via Metal-Catalyzed C–H Arylation of 8-Alkyl-thiazolo[5,4-f]-quinazolin-9-ones Designed by Fragment-Growing Studies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 2181. <a href="https://doi.org/10.3390/molecules23092181" title="DOI URL">https://doi.org/10.3390/molecules23092181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23092181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23092181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BKinase%252BInhibitors%252Bvia%252BMetal-Catalyzed%252BC%2525E2%252580%252593H%252BArylation%252Bof%252B8-Alkyl-thiazolo%25255B5%25252C4-f%25255D-quinazolin-9-ones%252BDesigned%252Bby%252BFragment-Growing%252BStudies%26aulast%3DCouly%26aufirst%3DFlorence%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">K.  Chitra</span>, <span class="hlFld-ContribAuthor ">G.  Saravanan</span>, <span class="hlFld-ContribAuthor ">V. Raja  Solomon</span>, <span class="hlFld-ContribAuthor ">M.T.  Sulthana</span>, <span class="hlFld-ContribAuthor ">B.  Narendhar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of quinazolines: Pharmacological significance and recent developments. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 628-685. <a href="https://doi.org/10.1016/j.ejmech.2018.03.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bquinazolines%25253A%252BPharmacological%252Bsignificance%252Band%252Brecent%252Bdevelopments%26aulast%3DAlagarsamy%26aufirst%3DV.%26date%3D2018%26volume%3D151%26spage%3D628%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosanna  Meine</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>, <span class="hlFld-ContribAuthor ">Hannes  Falke</span>, <span class="hlFld-ContribAuthor ">Lutz  Preu</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Conrad  Kunick</span>. </span><span class="cited-content_cbyCitation_article-title">Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 64. <a href="https://doi.org/10.3390/molecules23020064" title="DOI URL">https://doi.org/10.3390/molecules23020064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020064%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIndole-3-Carbonitriles%252Bas%252BDYRK1A%252BInhibitors%252Bby%252BFragment-Based%252BDrug%252BDesign%26aulast%3DMeine%26aufirst%3DRosanna%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thu Lan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Yann  Hérault</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 1183-1199. <a href="https://doi.org/10.1080/13543776.2017.1360285" title="DOI URL">https://doi.org/10.1080/13543776.2017.1360285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DDual-specificity%252Btyrosine%252Bphosphorylation-regulated%252Bkinase%252B1A%252B%252528DYRK1A%252529%252Binhibitors%25253A%252Ba%252Bsurvey%252Bof%252Brecent%252Bpatent%252Bliterature%26aulast%3DNguyen%26aufirst%3DThu%2BLan%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1183%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Lifang  Yu</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase targets in CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (3)
                                     , 303-314. <a href="https://doi.org/10.4155/fmc-2016-0214" title="DOI URL">https://doi.org/10.4155/fmc-2016-0214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0214%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Btargets%252Bin%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DGunosewoyo%26aufirst%3DHendra%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of methyl 9-anilinothiazolo[5,4-<i>f</i>]quinazoline-2-carbimidates <b>1</b>–<b>5</b> and DYRK1A and DYRK1B IC<sub>50</sub> (nM) values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selectivity analysis of <b>1</b> and <b>2</b>: Tm shifts (A) and IC<sub>50</sub> values (B) for selected kinases screened against <b>1</b> and <b>2</b>. n/a = no inhibition detected,  <i><sup>a</sup></i>Values from ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of DYRK2 in complexes with <b>1</b> and <b>2</b>. (A) |<i>F</i><sub>O</sub>| – |<i>F</i><sub>C</sub>| omitted map contoured at 3.0σ for the bound inhibitors. (B) Detailed interactions of the binding modes of the inhibitors with DRYK2. Magenta, dashed lines indicates potential hydrogen bonds, and water molecules are shown as cyan spheres. (C) Superimposition of DYRK2–<b>1</b>, DYRK1A–harmine (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>), DYRK1A–inhibitor <b>5j</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YLJ">4YLJ</a>), and DYRK1A–leucettine L41 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AZE">4AZE</a>) reveals that <b>1</b> occupies large space inside the DYRK ATP pocket. Note that numbering is according to DYRK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Modeling of <b>1</b> and <b>2</b> with DYRK1A/1B. Potential binding modes of <b>1</b> (left) and <b>2</b> (right) in DYRK1B calculated from structural modeling and docking studies (yellow, hinge region; red, catalytic loop; blue, DFG motif; purple, α-C helix; orange, catalytic lysine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ITC binding data of <b>2</b> with DYRK1A. Shown are the isotherms of raw titration heat (left), and the normalized binding heat with the single-site fitting (red line) (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/medium/jm-2016-010834_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Sequence alignment of DYRK family. (A) Sequence alignment of the region within the ATP binding pockets of DYRK family. Sequence similarity (%) to other DYRK kinases is represented by a blue bar. (B) Percentages of identity (bottom left quadrant) and similarity (top right quadrant) of kinase domain sequences from members of DYRK1 and DYRK2 subfamilies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-22/acs.jmedchem.6b01083/20161118/images/large/jm-2016-010834_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01083&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaudeix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Tau protein kinases: Involvement in Alzheimer’s disease</span> <span class="citation_source-journal">Ageing Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1016/j.arr.2012.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.arr.2012.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=22742992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=289-309&author=L.+Martinauthor=X.+Latypovaauthor=C.+M.+Wilsonauthor=A.+Magnaudeixauthor=M.-L.+Perrinauthor=C.+Yardinauthor=F.+Terro&title=Tau+protein+kinases%3A+Involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arr.2012.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein kinases: Involvement in Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Wilson, Cornelia M.; Magnaudeix, Amandine; Perrin, Marie-Laure; Yardin, Catherine; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289-309</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tau phosphorylation is regulated by a balance between tau kinase and phosphatase activities.  Disruption of this equil. was suggested to be at the origin of abnormal tau phosphorylation and thereby might contribute to tau aggregation.  Thus, understanding the regulation modes of tau phosphorylation is of high interest in detg. the possible causes at the origin of the formation of tau aggregates in order to elaborate protection strategies to cope with these lesions in Alzheimer's disease.  Among the possible and specific interventions that reverse tau phosphorylation is the inhibition of certain tau kinases.  Here, we extensively reviewed tau protein kinases, their physiol. roles and regulation, their involvement in tau phosphorylation and their relevance to AD.  We also reviewed the most common inhibitory compds. acting on each tau kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU914c2pCuALVg90H21EOLACvtfcHk0lgxRaMVfj6WqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D&md5=ce41a1cf982105ec7b3cc0ee6fcdf20b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2012.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2012.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DMagnaudeix%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.-L.%26aulast%3DYardin%26aufirst%3DC.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DTau%2520protein%2520kinases%253A%2520Involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2013%26volume%3D12%26spage%3D289%26epage%3D309%26doi%3D10.1016%2Fj.arr.2012.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Flajolet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-β formation by casein kinase I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4164</span><span class="refDoi"> DOI: 10.1073/pnas.0611236104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1073%2Fpnas.0611236104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-4164&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-%CE%B2+formation+by+casein+kinase+I&doi=10.1073%2Fpnas.0611236104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611236104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611236104%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-%25CE%25B2%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D4164%26doi%3D10.1073%2Fpnas.0611236104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Weinmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metternich, R.</span><span> </span><span class="NLM_article-title">Drug discovery process for kinase Inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1002/cbic.200500034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1002%2Fcbic.200500034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=15742380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=455-459&author=H.+Weinmannauthor=R.+Metternich&title=Drug+discovery+process+for+kinase+Inhibitors&doi=10.1002%2Fcbic.200500034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery process for kinase inhibitors</span></div><div class="casAuthors">Weinmann Hilmar; Metternich Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-9</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2pa-m03MzviEJCPKhJPuqfW6udTcc2eaRZg_v1RTt07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7isVOhsw%253D%253D&md5=62db1c09267fe56d34abef8d5b651750</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200500034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200500034%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26aulast%3DMetternich%26aufirst%3DR.%26atitle%3DDrug%2520discovery%2520process%2520for%2520kinase%2520Inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D455%26epage%3D459%26doi%3D10.1002%2Fcbic.200500034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-molecule+kinase+inhibitors%3A+an+analysis+of+FDA-approved+drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0lh02ySkcLJ61A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%253A%2520an%2520analysis%2520of%2520FDA-approved%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">FDA-approved small-molecule kinase inhibitors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span><span class="refDoi"> DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-approved+small-molecule+kinase+inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0lh02ySkcLJ61A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-approved%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rüben, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurzlbauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel b-carbolines as potent and selective DYRK1 kinase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0132453</span><span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+R%C3%BCbenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+b-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520b-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Varjosalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keskitalo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drogen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurkkala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vichalkovski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gstaiger, M.</span><span> </span><span class="NLM_article-title">The protein interaction landscape of the human CMGC kinase group</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1306</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.celrep.2013.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23602568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1306-1320&author=M.+Varjosaloauthor=S.+Keskitaloauthor=A.+Van+Drogenauthor=H.+Nurkkalaauthor=A.+Vichalkovskiauthor=R.+Aebersoldauthor=M.+Gstaiger&title=The+protein+interaction+landscape+of+the+human+CMGC+kinase+group&doi=10.1016%2Fj.celrep.2013.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Interaction Landscape of the Human CMGC Kinase Group</span></div><div class="casAuthors">Varjosalo, Markku; Keskitalo, Salla; Van Drogen, Audrey; Nurkkala, Helka; Vichalkovski, Anton; Aebersold, Ruedi; Gstaiger, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1306-1320</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cellular information processing via reversible protein phosphorylation requires tight control of the localization, activity, and substrate specificity of protein kinases, which to a large extent is accomplished by complex formation with other proteins.  Despite their crit. role in cellular regulation and pathogenesis, protein interaction information is available for only a subset of the 518 human protein kinases.  Here we present a global proteomic anal. of complexes of the human CMGC kinase group.  In addn. to subgroup-specific functional enrichment and modularity, the identified 652 high-confidence kinase-protein interactions provide a specific biochem. context for many poorly studied CMGC kinases.  Furthermore, the anal. revealed a kinase-kinase subnetwork and candidate substrates for CMGC kinases.  Finally, the presented interaction proteome uncovered a large set of interactions with proteins genetically linked to a range of human diseases, including cancer, suggesting addnl. routes for analyzing the role of CMGC kinases in controlling human disease pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOh3MUOGE47Vg90H21EOLACvtfcHk0lg-shyV9EoOMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Cmu7s%253D&md5=09d13e5b27edff77aeb206ab044e8da6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DVarjosalo%26aufirst%3DM.%26aulast%3DKeskitalo%26aufirst%3DS.%26aulast%3DVan%2BDrogen%26aufirst%3DA.%26aulast%3DNurkkala%26aufirst%3DH.%26aulast%3DVichalkovski%26aufirst%3DA.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DGstaiger%26aufirst%3DM.%26atitle%3DThe%2520protein%2520interaction%2520landscape%2520of%2520the%2520human%2520CMGC%2520kinase%2520group%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1306%26epage%3D1320%26doi%3D10.1016%2Fj.celrep.2013.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eirmbter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H.-G.</span><span> </span><span class="NLM_article-title">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">25893</span><span class="NLM_x">–</span> <span class="NLM_lpage">25902</span><span class="refDoi"> DOI: 10.1074/jbc.273.40.25893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1074%2Fjbc.273.40.25893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=9748265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=25893-25902&author=W.+Beckerauthor=Y.+Weberauthor=K.+Wetzelauthor=K.+Eirmbterauthor=F.+J.+Tejedorauthor=H.-G.+Joost&title=Sequence+characteristics%2C+subcellular+localization%2C+and+substrate+specificity+of+DYRK-related+kinases%2C+a+novel+family+of+dual+specificity+protein+kinases&doi=10.1074%2Fjbc.273.40.25893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases</span></div><div class="casAuthors">Becker, Walter; Weber, Yvonne; Wetzel, Kristiane; Eirmbter, Klaus; Tejedor, Francisco J.; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">25893-25902</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">DYRK1 is a dual specificity protein kinase presumably involved in brain development.  The kinase belongs to a new family of protein kinases comprising at least seven mammalian isoforms (DYRK1A, DYRK1B, DYRK1C, DYRK2, DYRK3, DYRK4A, and DYRK4B), the yeast homolog Yak1p, and the Drosophila kinase minibrain (MNB).  In rat tissues, DYRK1A is expressed ubiquitously, whereas transcripts for DYRK1B, DYRK2, DYRK3, and DYRK4 were detected predominantly in testes of adult but not prepuberal rats.  By fluorescence microscopy and subcellular fractionation, a green fluorescent protein (GFP) fusion protein of DYRK1A was found to accumulate in the nucleus of transfected COS-7 and HEK293 cells, whereas GFP-DYRK2 was predominantly detected in the cytoplasm.  DYRK1A exhibited a punctate pattern of GFP fluorescence inside the nucleus and was co-purified with the nuclear matrix.  Anal. of GFP-DYRK1A deletion constructs showed that the nuclear localization of DYRK1A was mediated by its nuclear targeting signal (amino acids 105-139) but that its characteristics subnuclear distribution depended on addnl. N-terminal elements (amino acids 1-104).  When expressed in Escherichia coli, DYRK1A, DYRK2, DYRK3, MNB, and Yak1p catalyzed their autophosphorylation on tyrosine residues.  The kinases differed in their substrate specificity in that DYRK2 and DYRK3, but not DYRK1A and MNB, catalyzed phosphorylation of histone H2B.  The heterogeneity of their subcellular localization and substrate specificity suggests that the kinases are involved in different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Q1vPoFEv4LVg90H21EOLACvtfcHk0lg-shyV9EoOMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1egt7g%253D&md5=4b8029c26149c1ecb9d65baf50dd978d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.40.25893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.40.25893%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DWetzel%26aufirst%3DK.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DJoost%26aufirst%3DH.-G.%26atitle%3DSequence%2520characteristics%252C%2520subcellular%2520localization%252C%2520and%2520substrate%2520specificity%2520of%2520DYRK-related%2520kinases%252C%2520a%2520novel%2520family%2520of%2520dual%2520specificity%2520protein%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D25893%26epage%3D25902%26doi%3D10.1074%2Fjbc.273.40.25893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunckley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulme, C.</span><span> </span><span class="NLM_article-title">Recent Advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A New avenue for a disease modifying treatment of Alzheimer’s?</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span><span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+Advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+A+New+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lg-shyV9EoOMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520Advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520A%2520New%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dirice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetere, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dančík, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B. K.</span><span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulates human β-cell proliferation</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1660</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span><span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=26953159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8D%C3%ADkauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulates+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A stimulates human beta-cell proliferation</span></div><div class="casAuthors">Dirice, Ercument; Walpita, Deepika; Vetere, Amedeo; Meier, Bennett C.; Kahraman, Sevim; Hu, Jiang; Dancik, Vlado; Burns, Sean M.; Gilbert, Tamara J.; Olson, David E.; Clemons, Paul A.; Kulkarni, Rohit N.; Wagner, Bridget K.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1660-1671</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Restoring functional β-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1).  While proliferation of existing β-cells is the primary means of β-cell replacement in rodents (2), it is unclear whether a similar principle applies to humans, as human β-cells are remarkably resistant to stimulation of division (3,4).  Here, we show that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increase proliferation in rodent and porcine islets (5), strongly and selectively increases human β-cell proliferation in vitro and in vivo.  Remarkably, 5-IT also increased glucose-dependent insulin secretion after prolonged treatment.  Kinome profiling revealed 5-IT to be a potent and selective inhibitor of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) and cell division cycle-like kinase families.  Induction of β-cell proliferation by either 5-IT or harmine, another natural product DYRK1A inhibitor, was suppressed by coincubation with the calcineurin inhibitor FK506, suggesting involvement of DYRK1A and nuclear factor of activated T cells signaling.  Gene expression profiling in whole islets treated with 5-IT revealed induction of proliferation- and cell cycle-related genes, suggesting that true proliferation is induced by 5-IT.  Furthermore, 5-IT promotes β-cell proliferation in human islets grafted under the kidney capsule of NOD-scid IL2Rgnull mice.  These results point to inhibition of DYRK1A as a therapeutic strategy to increase human β-cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLKPVi2wkdrVg90H21EOLACvtfcHk0ljWruObQ1nTHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWns7vP&md5=c383c8d1f2c1739252ad3cfe4361585c</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258D%25C3%25ADk%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulates%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Belgardt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammert, E.</span><span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapies</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1496</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapies&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapies%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span> </span><span class="NLM_article-title">DYRK1A: A potential drug target for multiple Down syndrome neuropathologies</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.2174/18715273113126660186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2174%2F18715273113126660186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=24152332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=26-33&author=W.+Beckerauthor=U.+Soppaauthor=F.+J.+Tejedor&title=DYRK1A%3A+A+potential+drug+target+for+multiple+Down+syndrome+neuropathologies&doi=10.2174%2F18715273113126660186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies</span></div><div class="casAuthors">Becker, Walter; Soppa, Ulf; Tejedor, Francisco J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Down syndrome (DS), the most common genetic cause of intellectual disability, is caused by the trisomy of chromosome 21.  MNB/DYRK1A (Minibrain/dual specificity tyrosine phosphorylation-regulated kinase 1A) has possibly been the most extensively studied chromosome 21 gene during the last decade due to the remarkable correlation of its functions in the brain with important DS neuropathologies, such as neuronal deficits, dendrite atrophy, spine dysgenesis, precocious Alzheimer's-like neurodegeneration, and cognitive deficits.  MNB/DYRK1A has become an attractive drug target because increasing evidence suggests that its overexpression may induce DS-like neurobiol. alterations, and several small-mol. inhibitors of its protein kinase activity are available.  Here, we summarize the functional complexity of MNB/DYRK1A from a DS-research perspective, paying particular attention to the capacity of different MNB/DYRK1A inhibitors to reverse the neurobiol. alterations caused by the increased activity of MNB/DYRK1A in exptl. models.  Finally, we discuss the advantages and drawbacks of possible MNB/DYRK1A-based therapeutic strategies that result from the functional, mol., and pharmacol. complexity of MNB/DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaG-2GxDUKR7Vg90H21EOLACvtfcHk0ljWruObQ1nTHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2nu7s%253D&md5=4b9c141d30bbf23f35f73b63e31f3e65</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.2174%2F18715273113126660186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715273113126660186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26atitle%3DDYRK1A%253A%2520A%2520potential%2520drug%2520target%2520for%2520multiple%2520Down%2520syndrome%2520neuropathologies%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D26%26epage%3D33%26doi%3D10.2174%2F18715273113126660186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=22918246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span></div><div class="casAuthors">Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation.  Members of the DYRK family phosphorylate many substrates, including crit. regulators of the cell cycle.  A recent report revealed that human DYRK2 actas as a neg. regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degrdn.  Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins.  DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degrdn. and stabilizing p27Kip1.  The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development.  This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnd37_01t3rVg90H21EOLACvtfcHk0ljWruObQ1nTHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVCqug%253D%253D&md5=df11959806a3cd7029023b270f74800f</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ionescu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1315</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span><span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0ligulVLDGT6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+Molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0ligulVLDGT6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520Molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/DYRK1B in cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1002/jcb.21451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1002%2Fjcb.21451" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=274-279&author=E.+Friedman&title=Mirk%2FDYRK1B+in+cancer&doi=10.1002%2Fjcb.21451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjcb.21451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.21451%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDYRK1B%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D274%26epage%3D279%26doi%3D10.1002%2Fjcb.21451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0ligulVLDGT6mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eYCxwyhk3QHxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onogi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eYCxwyhk3QHxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberholzer, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9312</span><span class="NLM_x">–</span> <span class="NLM_lpage">9330</span><span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lguJ56qnjXuuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominique, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6610</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.bmcl.2013.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.+C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615%26doi%3D10.1016%2Fj.bmcl.2013.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Falke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loäec, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu Jhaisha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span> </span><span class="NLM_article-title">10-Iodo-11<i>H</i>-indolo[3,2-<i>c</i>]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3131</span><span class="NLM_x">–</span> <span class="NLM_lpage">3143</span><span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Lo%C3%A4ecauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0ljBD3CSEZ1ohA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLo%25C3%25A4ec%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiéry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Novel 9-oxo-thiazolo[5,4-<i>f</i>]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.ejmech.2007.09.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1469-1477&author=C.+Log%C3%A9author=A.+Testardauthor=V.+Thi%C3%A9ryauthor=O.+Lozachauthor=M.+Blairvacqauthor=J.-M.+Robertauthor=L.+Meijerauthor=T.+Besson&title=Novel+9-oxo-thiazolo%5B5%2C4-f%5Dquinazoline-2-carbonitrile+derivatives+as+dual+cyclin-dependent+kinase+1+%28CDK1%29%2Fglycogen+synthase+kinase-3+%28GSK-3%29+inhibitors%3A+synthesis%2C+biological+evaluation+and+molecular+modeling+studies&doi=10.1016%2Fj.ejmech.2007.09.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DTestard%26aufirst%3DA.%26aulast%3DThi%25C3%25A9ry%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DNovel%25209-oxo-thiazolo%255B5%252C4-f%255Dquinazoline-2-carbonitrile%2520derivatives%2520as%2520dual%2520cyclin-dependent%2520kinase%25201%2520%2528CDK1%2529%252Fglycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1469%26epage%3D1477%26doi%3D10.1016%2Fj.ejmech.2007.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Testard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiéry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Thiazolo[5,4-<i>f</i>]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3419</span><span class="NLM_x">–</span> <span class="NLM_lpage">3423</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.bmcl.2006.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3419-3423&author=A.+Testardauthor=C.+Log%C3%A9author=B.+L%C3%A9gerauthor=J.-M.+Robertauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=V.+Thi%C3%A9ryauthor=T.+Besson&title=Thiazolo%5B5%2C4-f%5Dquinazolin-9-ones%2C+inhibitors+of+glycogen+synthase+kinase-3&doi=10.1016%2Fj.bmcl.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DTestard%26aufirst%3DA.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DL%25C3%25A9ger%26aufirst%3DB.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThi%25C3%25A9ry%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DThiazolo%255B5%252C4-f%255Dquinazolin-9-ones%252C%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3419%26epage%3D3423%26doi%3D10.1016%2Fj.bmcl.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Deau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levacher, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Convenient one-pot synthesis of <i>N</i><sup>3</sup>-substituted pyrido[2,3-<i>d</i>]-, pyrido[3,4-<i>d</i>]-, pyrido[4,3-<i>d</i>]-pyrimidin-4(3<i>H</i>)-ones, and quinazolin-4(3<i>H</i>)-ones analogs</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3518</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2013.04.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.tetlet.2013.04.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2rurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=3518-3521&author=E.+Deauauthor=D.+H%C3%A9douauthor=E.+Chossonauthor=V.+Levacherauthor=T.+Besson&title=Convenient+one-pot+synthesis+of+N3-substituted+pyrido%5B2%2C3-d%5D-%2C+pyrido%5B3%2C4-d%5D-%2C+pyrido%5B4%2C3-d%5D-pyrimidin-4%283H%29-ones%2C+and+quinazolin-4%283H%29-ones+analogs&doi=10.1016%2Fj.tetlet.2013.04.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Convenient one-pot synthesis of N3-substituted pyrido[2,3-d]-, pyrido[3,4-d]-, pyrido[4,3-d]-pyrimidin-4(3H)-ones, and quinazolin-4(3H)-ones analogs</span></div><div class="casAuthors">Deau, Emmanuel; Hedou, Damien; Chosson, Elizabeth; Levacher, Vincent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3518-3521</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A convenient microwave-assisted one-pot sequential synthesis provided access to novel pyridopyrimidin-4-(3H)-ones in good to excellent yields.  Anthranilic acid, 2- and 4-aminonicotinic acids, and 3-aminoisonicotinic acid were quant. converted into the analogous amidinoesters which undergo rapid cyclization in the presence of an amine.  E.g., irradn. of anthranilic acid and DMFDMA in DMF for 15 min., followed by addn. of PrNH2 and AcOH and another 15 min. of irradn. gave 87% N3-alkylated quinazolin-4-one deriv. (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKCaSGnvIbF7Vg90H21EOLACvtfcHk0liW0hF0F6gvXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2rurk%253D&md5=07aa0dcfb41c5b51d5b9e4c98cea9df2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.04.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.04.096%26sid%3Dliteratum%253Aachs%26aulast%3DDeau%26aufirst%3DE.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DChosson%26aufirst%3DE.%26aulast%3DLevacher%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DConvenient%2520one-pot%2520synthesis%2520of%2520N3-substituted%2520pyrido%255B2%252C3-d%255D-%252C%2520pyrido%255B3%252C4-d%255D-%252C%2520pyrido%255B4%252C3-d%255D-pyrimidin-4%25283H%2529-ones%252C%2520and%2520quinazolin-4%25283H%2529-ones%2520analogs%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D3518%26epage%3D3521%26doi%3D10.1016%2Fj.tetlet.2013.04.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Leblond, B.; Casagrande, A.-S.; Désiré, L.; Foucourt, A.; Besson, T.</span><span> </span><span class="NLM_article-title">DYRK1 inhibitors and uses thereof</span>. Patent WO 2013026806,<span class="NLM_x"> </span><span class="NLM_year">2013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Leblond&author=A.-S.+Casagrande&author=L.+D%C3%A9sir%C3%A9&author=A.+Foucourt&author=T.+Besson&title=DYRK1+inhibitors+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DDYRK1%2520inhibitors%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref24_2"><span>; <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">390018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%3BChem.+Abstr.+2013%2C+158%2C+390018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref24_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2013%26volume%3D158%26spage%3D390018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-<i>f</i>]quinazolines as DYRK1A inhibitors, Part I</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">15546</span><span class="NLM_x">–</span> <span class="NLM_lpage">15571</span><span class="refDoi"> DOI: 10.3390/molecules191015546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fmolecules191015546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25268714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15546-15571&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=L.+D%C3%A9sir%C3%A9author=A.-S.+Casagrandeauthor=B.+Leblondauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+Part+I&doi=10.3390%2Fmolecules191015546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I</span></div><div class="casAuthors">Foucourt, Alicia; Heou, Damien; Dubouilh-Benard, Carole; Desire, Laurent; Casagrande, Anne-Sophie; Leblond, Bertrand; Loaec, Nadege; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15546-15571, 26 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a library of novel 6,6,5-tricyclic thiazolo[5,4-f] quinazolines (forty mols.) I [R1 = 4-methoxyphenyl, 3,4-methylendioxyphenyl, 4-bromo-2-fluorophenyl, 3-chloro-2-fluorophenyl, 3,4-methylendioxy-5-bromophenyl; R2 = N≡C, H3CO(HN)C, H2N(O)C, (CH3)2N(HN)C, H5C6H2C, etc.] was achieved mainly under microwave irradn.  Dimroth rearrangement and 4,5-dichloro-1,2,3-dithiazolium chloride (Appel salt) chem. were assocd. for the synthesis of a novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile a versatile mol. platform for the synthesis of various bioactive derivs.  Kinase inhibition of the final compds. was evaluated on a panel of four Ser/Thr kinases (DYRK1A, CDK5, CK1 and GSK3) chosen for their strong implications in various regulation processes, esp. Alzheimer's disease (AD) and the results of this preliminary screening, thiazolo[5,4-f]quinazoline scaffolds constitutes a promising source of inspiration for the synthesis of novel bioactive mols.  Among the compds. of this novel chemolibrary, I [R1 = 4-methoxyphenyl, 3,4-methylendioxyphenyl, 4-bromo-2-fluorophenyl; R2 = H3CO(HN)C] inhibited DYRK1A with IC50 values ranging in the double-digit nanomolar range (40, 47 and 50 nM, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomAJWdE26QF7Vg90H21EOLACvtfcHk0liW0hF0F6gvXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLjO&md5=10eb0ad823d50a9fac328cc8ee7dbb4a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015546%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520Part%2520I%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15546%26epage%3D15571%26doi%3D10.3390%2Fmolecules191015546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazolo[5,4-<i>f</i>]quinazolines as DYRK1A inhibitors, Part II</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">15411</span><span class="NLM_x">–</span> <span class="NLM_lpage">15439</span><span class="refDoi"> DOI: 10.3390/molecules191015411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fmolecules191015411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25264830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=15411-15439&author=A.+Foucourtauthor=D.+H%C3%A9douauthor=C.+Dubouilh-Benardauthor=A.+Girardauthor=T.+Taverneauthor=A.-S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=B.+Leblondauthor=T.+Besson&title=Design+and+synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolines+as+DYRK1A+inhibitors%2C+Part+II&doi=10.3390%2Fmolecules191015411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II</span></div><div class="casAuthors">Foucourt, Alicia; Hedou, Damien; Dubouilh-Benard, Carole; Girard, Angelique; Taverne, Thierry; Casagrande, Anne-Sophie; Desire, Laurent; Leblond, Bertrand; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">15411-15439, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The convenient synthesis of a focused library (forty mols.) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines I (R = 4-MeOC6H4, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, etc.) was achieved mainly under microwave irradn.  A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile was used as a versatile mol. platform for the synthesis of various derivs.  Kinase inhibition, of the obtained final compds., was evaluated on a panel of two kinases (DYRK1A/1B) together with some known ref. DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41).  Compd. IC50 values were obtained and compared.  Five of the novel thiazolo[5,4-f]quinazoline derivs. prepd., I (R = 2,4-Cl2C6H3, 4-Cl-2-FC6H3, 2-F-4-MeOC6H3, 2,4-F2C6H3, 4-MeC6H4) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date.  DYRK1A/1B kinases are known to be involved in the regulation of various mol. pathways assocd. with oncol., neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing.  The compds. described in this communication constitute a highly potent set of novel mol. probes to evaluate the biol./pharmacol. of DYR1A/1B in such diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxocRjJkBbrVg90H21EOLACvtfcHk0liW0hF0F6gvXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSitLvM&md5=cefa4032d967cd704a189f3a62a1738d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191015411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191015411%26sid%3Dliteratum%253Aachs%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolines%2520as%2520DYRK1A%2520inhibitors%252C%2520Part%2520II%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D15411%26epage%3D15439%26doi%3D10.3390%2Fmolecules191015411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Coutadeur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyamine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalonde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucourt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pando, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span> </span><span class="NLM_article-title">A Novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: Effect on tau and amyloid pathologies in vitro</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.-S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=A+Novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+Effect+on+tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0ljuTY1NwZ5YLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3DA%2520Novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Effect%2520on%2520tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abbassi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, L.</span><span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+Molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0ljuTY1NwZ5YLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520Molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Throo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pando, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span> </span><span class="NLM_article-title">3D multicellular pancreatic cancer spheroids as drug screening tool for pharmacological evaluation of EHT 5372 and other Mirk/DYRK1B inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2620</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2014-2620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1158%2F1538-7445.AM2014-2620" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=2620&author=A.-S.+Casagrandeauthor=F.+Bachelotauthor=E.+Throoauthor=F.+Mah%C3%A9author=B.+Leblondauthor=T.+Bessonauthor=M.+P.+Pandoauthor=L.+D%C3%A9sir%C3%A9&title=3D+multicellular+pancreatic+cancer+spheroids+as+drug+screening+tool+for+pharmacological+evaluation+of+EHT+5372+and+other+Mirk%2FDYRK1B+inhibitors&doi=10.1158%2F1538-7445.AM2014-2620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2014-2620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2014-2620%26sid%3Dliteratum%253Aachs%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DBachelot%26aufirst%3DF.%26aulast%3DThroo%26aufirst%3DE.%26aulast%3DMah%25C3%25A9%26aufirst%3DF.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26atitle%3D3D%2520multicellular%2520pancreatic%2520cancer%2520spheroids%2520as%2520drug%2520screening%2520tool%2520for%2520pharmacological%2520evaluation%2520of%2520EHT%25205372%2520and%2520other%2520Mirk%252FDYRK1B%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D2620%26doi%3D10.1158%2F1538-7445.AM2014-2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.18632/genesandcancer.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25352950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOitbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=337-347&author=X.+Dengauthor=E.+Friedman&title=Mirk+kinase+inhibition+blocks+the+in+vivo+growth+of+pancreatic+cancer+cells&doi=10.18632%2Fgenesandcancer.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells</span></div><div class="casAuthors">Deng, Xiaobing; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">337-347, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">The Mirk/dyrk1B gene is upregulated and sometimes amplified in pancreatic ductal carcinomas.  In poor microenvironmental conditions Mirk mediates cell survival by maintaining cancer cells in a largely quiescent, noncycling state and by decreasing toxic ROS levels through maintaining expression of a series of antioxidant genes.  Premature entry into cycle, increased ROS levels, DNA damage, and apoptosis follow Mirk kinase depletion or inhibition.  Mirk kinase inhibitor EHT5372 treated Panc1 spheroids lost quiescence markers coincident with an increase in cyclin A showing entry into cycle, and exhibited DNA damage, apoptosis and smaller size.  EHT5372 treatment in vivo led to an increased fraction of Ki67 pos., cycling cells in Panc1 xenografts whose size was reduced.  Pdx-1-cre LSL/KrasG12D/Ink4a/Arf null B6 mice always develop pancreatic cancer, allowing only 30% survival by 8 wk, while each of the Mirk kinase inhibitor treated mice survived 8 wk.  Mirk inhibition led to a roughly four-fold increase in tumor αSMA-pos. fibroblasts and large stromal collagen-rich infiltrates in the pancreas that can restrain tumor growth.  The mTOR inhibitor RAD001 alone, or together with EHT5372, reduced pancreatic cancer size 30-fold, while the drug combination reduced the no. of microscopic tumor foci 2-fold compared to RAD001 alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJINa17jGfO7Vg90H21EOLACvtfcHk0ljuTY1NwZ5YLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOitbzP&md5=7b2b18b0514ba83873d3cf587fdc9368</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.29%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520kinase%2520inhibition%2520blocks%2520the%2520in%2520vivo%2520growth%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D337%26epage%3D347%26doi%3D10.18632%2Fgenesandcancer.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk kinase inhibition targets ovarian cancer ascites</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.18632/genesandcancer.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=25061503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=201-211&author=X.+Dengauthor=J.+Huauthor=M.+J.+Cunninghamauthor=E.+Friedman&title=Mirk+kinase+inhibition+targets+ovarian+cancer+ascites&doi=10.18632%2Fgenesandcancer.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk kinase inhibition targets ovarian cancer ascites</span></div><div class="casAuthors">Deng, Xiaobing; Hu, Jing; Cunningham, Mary J.; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">The Mirk/dyrk1B gene is commonly amplified or upregulated in ovarian cancers, and Mirk is an active kinase in these cancers.  Mirk mediates cancer cell survival by decreasing toxic ROS levels through maintaining expression of a series of antioxidant genes, possibly through its transcriptional activator functions.  Mirk has the unusual property of being most active in quiescent cancer cells because of marked transcriptional downregulation by Akt/mTOR signaling and by MEK/erk signaling in cycling cells.  Metastatic ovarian cancer cells form ascites, non-adherent multicellular aggregates floating within the peritoneal fluid.  Most ascites cancer cells are in a reversible quiescent, dormant state, suggesting that Mirk might be expressed in these quiescent cells and thus a therapeutic target.  The current studies show that ovarian cancer cell line spheroids that mimic ascites cancer spheroids were largely quiescent in G0/G1, and enriched in Mirk and the quiescence proteins, p130/Rb2 and the CDKI p27.  Mirk kinase inhibition in spheroids made from established cell lines and in patient-derived ascites cancer cell spheroids reduced spheroid vol., disrupted spheroid structure to single cells, increased apoptosis, and decreased cell nos.  Earlier studies had shown that the mTOR inhibitor RAD001 increased transcription of the Mirk/dyrk1B gene, so treatments combined RAD001 with the most active Mirk kinase inhibitor.  The no. of ascites cells from 9 patients was reduced a similar amt. by cisplatin, Mirk kinase inhibition or RAD001, but reduced substantially more, about 90%, by concurrent treatment with both the Mirk kinase inhibitor EHT5372 and RAD001.  Addn. of RAD001 increased the amt. of toxic ROS induced by Mirk kinase inhibition.  Two ascites samples taken one month apart gave similar drug responses, showing reproducibility of the techniques.  Thus Mirk/dyrk1B kinase may be a therapeutic target in ovarian cancer ascites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPcPoXXar7T7Vg90H21EOLACvtfcHk0lh9EwqcE2xxfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSktbvI&md5=a2f52e94abce9bcd3665fbefc75428b0</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.19%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DM.%2BJ.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520kinase%2520inhibition%2520targets%2520ovarian%2520cancer%2520ascites%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D201%26epage%3D211%26doi%3D10.18632%2Fgenesandcancer.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.18632/genesandcancer.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.18632%2Fgenesandcancer.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=24955215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=22-30&author=X.+Dengauthor=S.+E.+Mercerauthor=C.+Y.+Sunauthor=E.+Friedman&title=The+normal+function+of+the+cancer+kinase+Mirk%2Fdyrk1B+is+to+reduce+reactive+oxygen+species&doi=10.18632%2Fgenesandcancer.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species</span></div><div class="casAuthors">Deng, Xiaobing; Mercer, Stephen E.; Sun, Chi-Yu; Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Mirk kinase is a gene upregulated and sometimes amplified in pancreatic cancers and in ovarian cancers, but expressed at very low levels in most normal diploid cells except for skeletal muscle.  The muscle cell function of Mirk kinase selected for by cancer cells is unknown.  It is now shown that Mirk protein is expressed at low levels and is largely nuclear in cycling skeletal muscle C2C12 myoblasts, but is translocated to the cytoplasm and upregulated when myoblasts initiate differentiation, as shown by immunofluorescence staining and by cell fractionation.  Either Mirk depletion or Mirk kinase inhibition increased ROS levels in cycling C2C12 myoblasts.  However, Mirk protein is localized in the cytoplasm of mature muscle fibers, specifically in the fast twitch fibers of human skeletal muscle where toxic ROS levels are generated by muscle contraction.  C2C12 myoblasts at high d. in differentiation media fuse to form differentiated postmitotic myotubes that can contract.  A Mirk kinase inhibitor induced a dose-dependent increase in ROS in this model for fast twitch fibers of human skeletal muscle.  Efficient Mirk depletion in SU86.86 pancreatic cancer cells by an inducible shRNA decreased expression of eight antioxidant genes.  Thus both cancer cells and differentiated myotubes utilize Mirk kinase to relieve oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4KkpxAfgG7Vg90H21EOLACvtfcHk0lh9EwqcE2xxfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWqs7nN&md5=8d369a6ce403ecf1a3ec1429e7562f8b</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.1%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DMercer%26aufirst%3DS.%2BE.%26aulast%3DSun%26aufirst%3DC.%2BY.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DThe%2520normal%2520function%2520of%2520the%2520cancer%2520kinase%2520Mirk%252Fdyrk1B%2520is%2520to%2520reduce%2520reactive%2520oxygen%2520species%26jtitle%3DGenes%2520Cancer%26date%3D2014%26volume%3D5%26spage%3D22%26epage%3D30%26doi%3D10.18632%2Fgenesandcancer.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thompson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhansali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolzenburg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casagrande, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Désiré, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, J. D.</span><span> </span><span class="NLM_article-title">DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1084/jem.20150002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1084%2Fjem.20150002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=953-970&author=B.+Thompsonauthor=R.+Bhansaliauthor=L.+Dieboldauthor=D.+E.+Cookauthor=L.+Stolzenburgauthor=A.-S.+Casagrandeauthor=T.+Bessonauthor=B.+Leblondauthor=L.+D%C3%A9sir%C3%A9author=S.+Malingeauthor=J.+D.+Crispino&title=DYRK1A+controls+the+transition+from+proliferation+to+quiescence+during+lymphoid+development+by+destabilizing+Cyclin+D3&doi=10.1084%2Fjem.20150002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150002%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DB.%26aulast%3DBhansali%26aufirst%3DR.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DCook%26aufirst%3DD.%2BE.%26aulast%3DStolzenburg%26aufirst%3DL.%26aulast%3DCasagrande%26aufirst%3DA.-S.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DDYRK1A%2520controls%2520the%2520transition%2520from%2520proliferation%2520to%2520quiescence%2520during%2520lymphoid%2520development%2520by%2520destabilizing%2520Cyclin%2520D3%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26spage%3D953%26epage%3D970%26doi%3D10.1084%2Fjem.20150002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Stotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordanetto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medda, F.</span><span> </span><span class="NLM_article-title">DYRK1A inhibition as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.4155/fmc-2016-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.4155%2Ffmc-2016-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=27073990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=681-693&author=S.+Stotaniauthor=F.+Giordanettoauthor=F.+Medda&title=DYRK1A+inhibition+as+potential+treatment+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2016-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition as potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Stotani, Silvia; Giordanetto, Fabrizio; Medda, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">681-696</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In total, 47,500,000 people worldwide are affected by dementia and this no. is estd. to double by 2030 and triple within 2050 resulting in a huge burden on public health.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of dementia, accounting for 60-70% of all the cases.  The cause of AD is still poorly understood but several brain abnormalities (e.g., loss of neuronal connections and neuronal death) have been identified in affected patients.  In addn. to the accumulation of β-amyloid plaques in the brain tissue, aberrant phosphorylation of tau proteins has proved to increase neuronal death.  DYRK1A phosphorylates tau on 11 different Ser/Thr residues, resulting in the formation of aggregates called 'neurofibrillary tangles' which, together with amyloid plaques, could be responsible for dementia, neuronal degeneration and cell death.  Small mol. inhibition of DYRK1A could thus represent an interesting approach toward the treatment of Alzheimer's and other neurodegenerative diseases.  Herein we review the current progress in the identification and development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIkkQdSVqce7Vg90H21EOLACvtfcHk0lh9EwqcE2xxfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D&md5=7f90e6dc11edc4d395371d7ad07460d7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0013%26sid%3Dliteratum%253Aachs%26aulast%3DStotani%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMedda%26aufirst%3DF.%26atitle%3DDYRK1A%2520inhibition%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D681%26epage%3D693%26doi%3D10.4155%2Ffmc-2016-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/Dyrk1B kinase in ovarian cancer</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5575</span><span class="refDoi"> DOI: 10.3390/ijms14035560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.3390%2Fijms14035560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=23528858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Gjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=5560-5575&author=E.+Friedman&title=Mirk%2FDyrk1B+kinase+in+ovarian+cancer&doi=10.3390%2Fijms14035560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mirk/dyrk1B kinase in ovarian cancer</span></div><div class="casAuthors">Friedman, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5560-5575</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Mirk/dyrk1B kinase is expressed in about 75% of resected human ovarian cancers and in most ovarian cancer cell lines with amplification in the OVCAR3 line.  Mirk (minibrain-related kinase) is a member of the Minibrain/dyrk family of related serine/threonine kinases.  Mirk maintains cells in a quiescent state by stabilizing the CDK inhibitor p27 and by inducing the breakdown of cyclin D isoforms.  Mirk also stabilizes the DREAM complex, which maintains G0 quiescence by sequestering transcription factors needed to enter cycle.  By entering a quiescent state, tumor cells can resist the nutrient deficiencies, hypoxic and acidic conditions within the tumor mass.  Mirk maintains the viability of quiescent ovarian cancer cells by reducing intracellular levels of reactive oxygen species.  CDKN2A-neg. ovarian cancer cells treated with a Mirk kinase inhibitor escaped G0/G1 quiescence, entered cycle with high ROS levels and underwent apoptosis.  The ROS scavenger N-acetyl cysteine reduced the extent of cancer cell loss.  In contrast, the Mirk kinase inhibitor slightly reduced the fraction of G0 quiescent diploid epithelial cells and fibroblasts, and the majority of the cells pushed into cycle accumulated in G2 + M.  Apoptotic sub-G0/G1 cells were not detected.  Thus, normal cells were spared because of their expression of CDK inhibitors that blocked unregulated cycling and Mirk kinase inhibitor-treated normal diploid cells were about as viable as untreated controls.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonJpdV3yRq8bVg90H21EOLACvtfcHk0liFf-QrR5_iWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Gjtrc%253D&md5=7514fe15aa23d30516abcc7452ae116c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fijms14035560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14035560%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDyrk1B%2520kinase%2520in%2520ovarian%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D5560%26epage%3D5575%26doi%3D10.3390%2Fijms14035560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/dyrk1B kinase is upregulated following inhibition of mTOR</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1968</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span><span class="refDoi"> DOI: 10.1093/carcin/bgu058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;key=10.1093%2Fcarcin%2Fbgu058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1968-1976&author=X.+Dengauthor=J.+Huauthor=D.+Z.+Ewtonauthor=E.+Friedman&title=Mirk%2Fdyrk1B+kinase+is+upregulated+following+inhibition+of+mTOR&doi=10.1093%2Fcarcin%2Fbgu058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgu058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgu058%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252Fdyrk1B%2520kinase%2520is%2520upregulated%2520following%2520inhibition%2520of%2520mTOR%26jtitle%3DCarcinogenesis%26date%3D2014%26volume%3D35%26spage%3D1968%26epage%3D1976%26doi%3D10.1093%2Fcarcin%2Fbgu058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR','PDB','3ANR'); return false;">PDB: 3ANR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YLJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YLJ','PDB','4YLJ'); return false;">PDB: 4YLJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AZE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AZE','PDB','4AZE'); return false;">PDB: 4AZE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC','PDB','5LXC'); return false;">PDB: 5LXC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD','PDB','5LXD'); return false;">PDB: 5LXD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i8"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01083">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88036"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01083">10.1021/acs.jmedchem.6b01083</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed synthesis of <b>1</b> (EHT 5372) and <b>2</b> (EHT 1610), <sup>1</sup>H NMR spectra, and HPLC chromatograms for <b>1</b> and <b>2</b>, details of docking experiments, protein expression and purification, thermal stability assays, docking experiments of <b>1</b> and <b>2</b> in DYRK1A and DYRK1B, isothermal titration calorimetry (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_001.pdf">jm6b01083_si_001.pdf (624.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01083/suppl_file/jm6b01083_si_002.csv">jm6b01083_si_002.csv (0.43 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The structure coordinates have been deposited in the Protein Data Bank: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXC">5LXC</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LXD">5LXD</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01083%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01083" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679991fd78e23d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
